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Abstract 
 
Retinal vessel occlusion is among the leading causes of vision loss. The functional & 
cellular effects of acute loss of blood flow have not been investigated fully, and current 
treatments only address secondary complications of ischemic damage. This work has 
developed new tools with which to investigate retinal blood flow and glial Ca2+ signaling 
in health and disease. Retinal blood flow in the rat was examined by using an imaging 
technique known as laser speckle flowmetry (LSF) to generate two dimensional maps of 
blood flow changes. We demonstrated that the inner retinal and choroidal circulations 
could be imaged noninvasively, and used this technique to study functional hyperemia 
responses in the retina. We discovered that blood flow increases were more difficult to 
evoke in areas away from primary arterioles, suggesting that capillary regulation of 
functional hyperemia is unlikely. To determine the role of glial Ca2+ signaling on 
neurovascular coupling, we developed a method of injecting Ca2+ indicator dyes and 
caged Ca2+ compounds into the vitreous, near the retinal surface. This study 
demonstrated that glial Ca2+ signaling plays a role in retinal blood flow regulation. Finally, 
using a variety of imaging tools, including LSF, we discovered that retinal spreading 
depression (RSD) is evoked by acute retinal ischemia. RSD in the in vivo, vascular 
retina has never previously been seen. Spreading depression in the cortex has been 
shown to play a role in expanding brain injuries. Our observation of RSD is an important 
finding that carries exciting clinical implications and may be a promising therapeutic 
target for preventing vision loss after retinal ischemia. 
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CHAPTER 1: Introduction 
 
 
The retina is a highly specialized sensory tissue responsible for processing light and 
converting it to neural signals that are analyzed as visual stimuli. As an extension of the 
central nervous system (CNS), the retina is structurally and functionally similar to the 
brain, and similarly, has very high metabolic demands. Consequently, loss of blood flow 
to the retina results injury and cell death that lead to vision loss. The time course of 
retinal ischemia has been described histologically to chronicle cellular injury patterns and 
clinically to understand its natural history and prognosis. Animal models have provided 
mechanistic insights into the secondary complications of retinal vessel occlusion. 
However, much less is understood about the functional response to retinal ischemia at 
the cellular level. In the brain, injury is accompanied by a phenomenon known as cortical 
spreading depression (CSD), which depolarizes cells, increases glial Ca2+ signaling, 
massively disrupts ion homeostasis, and increases metabolic demand, ultimately 
exacerbating the injury. Nothing like CSD has ever been observed in the in vivo retina. 
The aim of this work has been to characterize the cellular, particularly glial, effects of 
retinal ischemia in an in vivo rodent model, and to determine whether CSD-like events 
also occur in the in vivo retina in response to ischemic injury. 
Retinal anatomy 
To appreciate the consequences of ischemic injury in the retina, it is important to 
understand the retina’s cellular and vascular anatomy. This section aims to provide a 
very brief overview of these topics, but more detailed discussions are provided by 1-3. 
 
The neural retina is a thin tissue found in the posterior part of the eye, between the 
retinal pigment epithelium and the vitreous body3, and is organized into specific cell 
layers (Fig. 1.1) that are defined by the path along which visual information is processed. 
The retina has two nuclear layers that contain the cell bodies of retinal cells, and two 
plexiform layers in which synaptic transmission and modulation of information flow 
occurs. The outer layers lie deeper, while the inner layers are closer to the vitreous 
body. In order, starting deepest, these layers are: (1) the outer nuclear layer (ONL), 
made up of the cell bodies of photoreceptors, is where these cells convert photons into 
chemical signals; (2) the outer plexiform layer (OPL) is the site of synaptic transmission 
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between photoreceptor cells and bipolar cells; (3) the inner nuclear layer (INL) contains 
the cell bodies of bipolar cells, but also contains modulatory Müller cells and retinal 
interneurons (horizontal and amacrine cells), strategically positioning them between the 
two synaptic layers for effective modulation of retinal processing4; (4) the inner plexiform 
layer (IPL), where bipolar cells signal to retinal ganglion cells; (5) the ganglion cell layer 
(GCL) is comprised of the cell bodies of retinal ganglion cells (RGCs) and amacrine 
cells; and (6) the nerve fiber layer (NFL), home to retinal astrocytes and where the axons 
of RGCs converge on the optic disc to bundle together and exit the retina as the optic 
nerve1.  
 
The retinal circulation (Fig. 1.2) reflects the laminar cellular organization of the retinal 
tissue. Two primary vascular beds supply the retina2, 3, 5: (1) the choroid, characterized 
by its high rate of blood flow and large, dense, fenestrated capillaries, lies behind the 
retinal pigment epithelium and feeds the metabolically demanding outer retina6; and (2) 
the inner retinal, or superficial, circulation supplies the inner retina and has been the 
focus of this thesis work. The central retinal artery (CRA), a branch of the ophthalmic 
artery, enters the retina at the optic disc and gives rise to the inner retinal vascular bed. 
At the optic disc, the CRA branches into primary branch retinal arterioles that radiate 
outward towards the retinal periphery. As terminal vessels, they do not anastomose with 
each other5. Rather, these arterioles supply three serially arranged capillary beds that 
are strategically positioned in series: (i) in the ganglion cell layer, (ii) in the junction 
between the inner plexiform and the inner nuclear layers, and (iii) in the junction between 
the inner nuclear and the outer plexiform layers7. All three capillary beds drain into small 
venules to bring blood to the branch retinal venules. Like the primary branch retinal 
arterioles, these venules also have a radial arrangement at the vitreal surface of the 
retina and drain into the central retinal vein at the optic disc2. 
 
Notably, the capillary bed organization of the inner retina ensures that active synaptic 
zones receive adequate metabolic support while maintaining relative vascular 
sparseness so as not to interfere with light passage to photoreceptors8. When the partial 
pressure of O2 is measured at different retinal depths, the distribution of tissue O2 
reflects this trade-off between vascular density and providing metabolic support: tissue 
O2 tension is high at the retinovitreous border from the superficial capillary bed but 
quickly drops to its nadir of ~3 mmHg in the highly active inner plexiform layer where the  
4 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.1. Laminar organization of the retina. Retinal neurons are orange and retinal 
glia are yellow. RPE, retinal pigment epithelium. ONL, outer nuclear layer. OPL, outer 
plexiform layer. INL, inner nuclear layer. IPL, inner plexiform layer. GCL, ganglion cell 
layer. NFL, nerve fiber layer. Note how Müller cell processes extend into the plexiform 
layers. Red circles represent the inner retinal circulation, with the larger circle 
representing the primary branch vessels, and the three smaller circles representing the 
three capillary beds that arise from the inner retinal circulation. Modified from 9. 
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Figure 1.2. Retinal circulation. Cross sectional depiction of the optic nerve and the 
blood vessels that run with it. The point on the retinal surface where the central retinal 
artery enters and the central retinal vein exits the retina is the optic disc. From 3.    
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intermediate capillary layer is the least dense7. Tissue O2 tension is rescued slightly by 
the deepest capillary layer, but drops again due to the high metabolic activity of the 
photoreceptor inner segments before steadily increasing again with as measurements 
move closer to the choroid8. 
Müller cells 
Müller cells are the principle glial cells of the retina and function analogously to the 
brain’s astrocytes. Unlike astrocytes, however, Müller cells have a unique radial glia-like 
morphology because they extend from the subretinal space to the vitreous body, 
spanning the entire thickness of the retina10, 11. As a result, they are ideally positioned to 
provide metabolic and functional support to all retinal layers. Among other functions, 
Müller cells take up and recycle neurotransmitters. They have transporters for a variety 
of transmitters, including glutamate10. Not only does such uptake effectively help 
terminate synaptic transmission to fine-tune signaling, but subsequent conversion of 
glutamate to glutamine provides the substrate for synthesizing the anti-oxidant, 
glutathione, and supplements other cells with the necessary precursor for glutamate or 
GABA synthesis10, 12, 13. Müller cells can also modulate neuronal activity by releasing 
gliotransmitters such as D-serine14, ATP15, and glutamate15, 16 onto neurons. Additionally, 
Müller cells play a critical role in maintaining the extracellular milieu to optimize neuronal 
signaling. Neuronal activity results in extracellular K+ increases, and without rapid 
clearance of this ion, cells would depolarize. Müller cells provide a functional network to 
spatially buffer local K+ increases17 by taking up K+ ions through Kir4.1 channels18 and 
depositing K+ in areas away from the site of neuronal activity in the vitreous humor19, 20.  
Finally, Müller cells are critical for regulating blood flow21. This is discussed in the next 
section. 
Metabolic support: blood flow 
The retinal circulation delivers O2 and glucose to retinal cells and takes away metabolic 
byproducts. Therefore, ensuring adequate blood flow is critical for proper retinal function. 
Two factors determine blood flow through a tissue: (1) the perfusion pressure driving 
blood into the vascular bed, and (2) the resistance of the circulatory bed being perfused. 
In the retina, perfusion pressure is determined by the difference between arterial 
pressure in the ophthalmic artery and the intraocular pressure (IOP)22. Since arterial 
pressure and IOP can vary, autoregulation ensures physiological blood flow across 
variable parameters. The mechanisms underlying autoregulation of retinal blood flow are 
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controversial. In the CNS, blood flow is regulated by signaling molecules as well as by 
perivascular nerves that control blood vessel tone23. While there is evidence for 
autonomic innervation of retinal vessels24, retinal vessel tone is thought to be controlled 
largely by humoral mechanisms22. For example, nitric oxide (NO) appears to regulate 
vascular tone in human subjects in response to changes in blood pressure, but not 
IOP25. Additionally, retinal endothelial cells have mechano-receptors that can respond to 
changes in perfusion pressure and activate myocytes accordingly22. Recently, new 
evidence has emerged that release of ATP, likely from glial cells, is critical for 
maintaining vascular tone in the inner retinal circulation26. 
 
While autoregulation is responsible for general blood flow homeostasis, functional 
hyperemia dictates finer control of retinal blood flow. This phenomenon, first described 
by Mosso in 188027 and then Roy and Sherrington a decade later28, occurs when blood 
flow increases locally in areas of increased neuronal activity through a mechanism 
known as neurovascular coupling. In the brain, diffusible molecules are responsible for 
vascular responses to neuronal activity. In particular, NO is a potent vasodilator and is 
produced by neurons in response to NMDA receptor activation by glutamate29, 30. 
However, astrocytes (from herein, referred to as “glia”) are really the central players in 
mediating neurovascular coupling because their processes border synapses and 
terminate on blood vessels, ideally positioning them to sense neuronal activity and 
mediate vascular responses. In the retina and in the brain, synaptically release 
neurotransmitters diffuse to receptors on glial cells to initiate IP3-mediated Ca2+ 
increases. Glial Ca2+ activates the enzyme phospholipase A2 (PLA2), which metabolizes 
membrane phospholipids into vasoactive metabolites. Specifically, synthesis and release 
of epoxyeicosatrienoic acids (EETs) and prostaglandin E2 (PGE2) result in local 
vasodilation, while 20-hydroxy-eicosatetraenoic acid (20-HETE) produces 
vasoconstriction30. This same signaling system with Müller cells as the central players 
functions in the retina, too21, and Chapters 3 and 4 demonstrate this phenomenon. 
Ischemic injury in the brain 
Stroke is the second leading cause of death worldwide. Defined as the sudden loss of 
perfusion to the brain, strokes can be classified as either ischemic (~85%, owing to 
vascular embolism) and the focus of this work, or hemorrhagic (< 15%, owing to vascular 
rupture). Hemorrhagic strokes are often lethal, but ischemic strokes carry a 58.4% 
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survival rate and high rates of secondary morbidity. In fact, health complications due to 
stroke came at a cost of over 7 billion dollars in the USA in 201031. Current therapies for 
stroke are limited to interventions that try to reestablish blood flow, such as tissue 
plasminogen activator (tPA) or endovascular mechanical thrombectomy, and do little to 
curb secondary complications. tPA, in particular, is only approved for use within three 
hours of the onset of symptoms and carries a risk of hemorrhagic adverse events31. To 
complicate matters further, reperfusion after a period of ischemia results in reperfusion 
injury, a paradoxical phenomenon in which delivery of nutrients suddenly provides cells 
with enough energy to activate apoptotic signaling cascades and generate damaging 
reactive oxygen species5, 31.  
 
A variety of animal models have been employed to study the evolution of ischemic injury 
in the CNS. These experimental systems can create strokes of varying severity by 
altering duration and method of ischemia. For example, cell culture or brain slices can be 
subjected to oxygen glucose deprivation32. In vivo, the popular middle cerebral artery 
occlusion generates large strokes33 in a distribution akin to strokes commonly occurring 
in humans, and can be made reversible or permanent. Smaller strokes can be produced 
using a technique called photothrombosis33-35. This method relies on a dye, Rose 
Bengal, whose photoactivation produces localized thrombi by way of local damage to the 
endothelium35. These common models, and many others, have greatly advanced current 
knowledge about ischemic damage. From these studies, several universal observations 
have been made. 
 
Firstly, ischemia in the nervous system results in excitotoxicity, a specific type of 
damage that is unique to the nervous system5. The brain’s high demand for glucose and 
O2 comes from heavy cellular reliance on tightly maintained ion gradients and their rapid 
restoration after neuronal activity. As a result, disproportionately large amounts of ATP 
are required to keep Na+-K+ pumps running36. When blood flow is suddenly lost and 
oxidative phosphorylation is disrupted, ion gradients fail within minutes, causing cells to 
depolarize and release glutamate. This sequence of events produces cell damage via 
several mechanisms: (1) additional depolarization due to transmitter binding at ionotropic 
receptors (NMDA, AMPA, and kainate) causes shifts in Na+ and Cl-, resulting in excess 
water entry into cells and leading to cell swelling and lysis5; and (2) glutamate binding at 
NMDA receptors results in excess Ca2+ influx that can activate a variety of enzymes that 
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promote cytoskeletal and DNA damage, and overload mitochondrial buffering 
mechanisms and initiate cell death cascades5, 31.  
 
Secondly, glial cells contribute to ischemic injury in several ways. First, these cells also 
serve as a glutamate source during excitotoxicity. Since glial glutamate uptake 
mechanisms rely on the Na+ gradient, loss of this gradient impairs glutamate uptake by 
glia36. And under conditions of increased extracellular K+, the glial glutamate transporter 
reverses its transport direction causing glia to actively contribute to the rise in 
extracellular glutamate37. Additionally, it is known that glial Ca2+ increases under 
pathological conditions in the CNS38, 39, including in ischemia34, 36. Two forms of glial Ca2+ 
can occur: (1) oscillations limited to single cells, and (2) multicellular Ca2+ waves40. 
However, the functional consequences of this Ca2+ signaling remain controversial. There 
is some evidence that glial Ca2+ signaling may be protective. One study showed that 
stimulation of glial Ca2+ by activating the purinergic P2Y1 receptor, ischemia-induced 
dendritic damage and cell death was decreased41. Others have shown that glial Ca2+ is 
associated with glutamate release that increases injury34, 42. The effect of ischemic glial 
Ca2+ signaling on glial blood flow regulation is unknown. It has been observed that 
pericytes, contractile cells that enwrap capillaries, contract and stiffen after ischemia, 
limiting parenchymal blood flow43, 44. One speculation is that glial Ca2+ signaling may 
result in the release of a preponderance of vasoconstrictors which could account for 
some of the observed pericyte constrictions. However, this hypothesis is yet untested. 
 
Thirdly, the immune system plays a critical role in injury expansion and tissue 
remodeling after ischemic infarction. In the acute phase, thrombus formation and early 
injury activate components of the innate immune system (ie: microglia), resulting in a 
positive feedback loop of cytokine release and increased trafficking of more immune 
cells to the area of damage45. While leukocytes do play a role in injury expansion, the 
mechanisms of their involvement are not yet clear46. Over time, the peripheral 
boundaries of the dead tissue become walled off by reactive astrocytes, and the dead 
tissue is replaced by a scar. Interestingly, recent evidence has come to reveal that this 
scar remains populated by immune cells that continue to release cytokines and other 
factors that may affect the function of nearby healthy tissue. This has become the new 
hypothesis for the mechanisms underlying vascular dementia, a common complication of 
stroke in human patients. In support of this theory, it has been shown that stroke scars in 
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mice become populated with B-cells several weeks after the stroke, and this is 
associated with cognitive deficits; if B-cells are depleted, cognitive deficits are delayed33.  
 
Lastly, ischemic injury follows a circumscribed course during which loss of blood flow 
generates a non-perfused area of tissue, known as the core, and a surrounding 
hypoperfused penumbra. It has become clear that saving cells from the core is a futile 
task. However, the penumbra is a dynamic region in which function is impaired, but 
which can be rescued by timely intervention. Conversely, if left under-perfused, the 
penumbra can deteriorate into an expanding core. Additionally, the penumbra is the 
source of peri-infarct depolarizations, a type of cortical spreading depression that can 
expand the ischemic infarct47, 48, discussed in the following section.  
Cortical spreading depression (CSD) 
CSD is a phenomenon that was first described by the Brazilian physiologist Aristides 
Leão in the rabbit49. In trying to evoke epileptic seizures, Leão observed that an intense 
electrical stimulus produced a silencing of neuronal activity that spread across the 
cortical surface. This wave of depressed signaling also appeared to have a dramatic 
effect on blood flow. These original findings were initially taken for a curious 
phenomenon without physiological relevance. However, strong evidence has 
accumulated implicating cortical spreading depression as the mechanism that underlies 
migraine auras50, 51. More recently, CSD has also been shown to spontaneously occur in 
response to severe acute trauma to the brain, such as ischemic stroke, subarachnoid 
hemorrhage, or traumatic brain injury52. Notably, CSD only affects grey matter and 
cannot be sustained by white matter53. 
 
CSD is a complex phenomenon that involves massive depolarization of neurons that is 
accompanied by dramatic shifts in ion gradients and extracellular accumulation of 
neurotransmitters. While the physiological trigger for CSD remains unknown, there is 
agreement that synchronous depolarization of a critical volume of tissue, ~1 mm3 is 
required54. The subsequent rise in extracellular K+ is rapid and massive: [K+]e elevates 
from ~3 mM to more than 10-fold. Meanwhile, Na+, Cl-, and Ca2+ travel down their ionic 
gradients and enter cells53, 54.  
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This loss of ion homeostasis has significant consequences. Firstly, the substantial 
increase in [K+]e overwhelms K+ buffering and clearance mechanisms19. As a result, K+ 
ions accumulate in the extracellular space, diffuse outward, and promote depolarization 
of neighboring tissue, thereby propagating the CSD wave. Secondly, depolarization and 
Ca2+ entry promote the release of neuro- and gliotransmitters. These signaling 
molecules are then free to act synaptically36 and extra-synaptically55 to enhance and 
propagate the CSD depolarization. Finally, entry of ions into cells is accompanied by 
water influx to cause cell swelling and a decrease in extracellular volume. Cell swelling 
accounts for changes in reflectance properties of the tissue, a characteristic that can be 
used to image CSD as an intrinsic optical signal (IOS) by reflectance microscopy56. 
Increased cell volume further promotes transmitter release via volume-activated 
channels57. Cell swelling also decreases extracellular volume, effectively raising the 
extracellular concentrations of K+ and neurotransmitters, further promoting 
depolarization (Somjen). Together, these mechanisms allow CSD waves to propagate 
out from the initiation point at a rate of ~3 mm/min until they eventually extinguish49, 53, 54, 
58. 
 
Electrophysiologically, CSD is characterized by a transient increase in neuronal firing, 
followed by a prolonged period of neuronal silence lasting from ~5 minutes49, 59 to 
several hours if CSD occurs in injured tissue60. Since neuronal spiking activity depends 
on maintained physiological ion gradients, the period of electrical silence is determined 
by the time it takes to restore ion gradients following a CSD episode53. Spiking activity 
alone is a poor marker for CSD since, under pathological conditions, spiking activity can 
be silenced by mechanisms other than CSD54, 61. Compared to very rapid action 
potentials that occur on the order of milliseconds, the massive depolarization of CSD 
takes several seconds to develop and resolve. As a result, it is more reliable to measure 
extracellular changes in DC potential where CSD manifests as a negative shift in 
potential that can be up to 30 mV or more in amplitude and last from a few second to 
over two minutes54, 62. 
 
CSD also causes a complex series of blood flow changes. These changes can be 
divided into four phases. The first phase is a rapid and transient vasoconstriction that 
coincides with63 or just precedes64 the drop in DC potential. Second, there is a period of 
transient hyperemia that typically begins shortly after the negative DC shift. This 
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increase in blood flow only lasts a few minutes, but generally outlasts the 
electrophysiological changes that occur with CSD54. Third, there is a smaller, secondary 
hyperemic response64. Finally, an extended oligemia remains for over an hour54, 65 after 
the tissue has otherwise recovered from the 2-6 minute long CSD episode66.  
 
The molecular signals driving each of these blood flow phases remain unclear. For 
example, the initial vasoconstriction is thought to be caused by the substantial K+ rise at 
the onset of SD, since high K+ has been shown to depolarize vascular smooth muscle 
cells63, 67. However, this initial vasoconstriction is most pronounced for only the first CSD 
wave; subsequent CSD episodes result in only slight vasoconstrictions, if any at all63. It 
is generally accepted that glial cells play a central role in coupling neuronal activity to 
changes in blood flow, as discussed earlier. In this model under healthy conditions, the 
synthesis of dilating molecules prevails over constricting molecules30. However, there is 
evidence that this balance shifts in CSD, resulting in increased 20-HETE, a 
vasoconstrictor. This shift may account for the prolonged oligemia that follows CSD68. 
However, it is unclear when this shift occurs and how it is regulated. Generally, these 
blood flow changes have been difficult to study because their courses are influenced by 
CSD wave frequency63, animal species54, anesthesia69, blood pressure54, and a plethora 
of other variables. Nevertheless, it is clear that CSD results in pronounced changes in 
blood flow that may contribute to CSD’s pathophysiological effects. 
     
CSD is a highly metabolically taxing phenomenon. The massive shifts in ion gradients 
must be restored, a process that is dependent on ATP-driven Na+-K+ pumps53, 54. As a 
result, in the minutes that follow a CSD episode, glucose metabolism, glycogen 
breakdown, lactate production, and tissue demand for O2 increase dramatically54. When 
tissue is healthy, recovery from CSD occurs without any lasting consequences. 
However, in the face of injury, these added metabolic demands exacerbate tissue 
damage and increase cell death, resulting in a perpetuating cascade of additional 
injury47, 48. Additionally, in the ischemic rat cortex, frequent CSD waves have been 
shown to induce excitotoxic lesions in a glutamate-dependent manner62. In human 
patients recovering from subarachnoid hemorrhage, traumatic brain injury, or malignant 
stroke, spontaneous SD episodes have been linked to delayed neurological deficits and 
increased infarct volume60.  
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Retinal spreading depression (RSD) 
Spreading depression has also been studied in the retina. Less than a decade after the 
discovery of CSD, Gouras observed a similar phenomenon in the isolated toad retina, 
appearing as a milky wave that spread over the retinal surface66. Since this initial 
observation, RSD has been widely studied in many animal models, including chick59, 70, 
71, frog72, 73, carp74, and salamander53.  
 
RSD studies have revealed that spreading depression in the retina recapitulates CSD. 
RSD can be elicited by mechanical or electrical stimulation59, 66, ions (high K+ or low Cl- 
media)71-74, glutamate55, 75, free radicals70, and injury76. RSD propagates at a velocity of 
1-10 mm/min77, is accompanied by cell swelling56, and results in a negative shift in DC 
potential and silencing of spontaneous neuronal activity66, 77. Also like in the brain, RSD 
is associated with cell death, as demonstrated by Yu et al.76. They showed that a cut 
injury in the hypoglycemic chick retina can trigger SD episodes that are correlated with 
increased cell death in the macula. These macular lesions can themselves become new 
foci for new SD waves76.  
 
To date, with the exception of one report on cat eyecup78, all RSD studies have used 
species with avascular retinas. Investigating RSD in these model systems have been 
considered an ideal experimental paradigm in which to study the effects of spreading 
depression on neural tissue, independent of vascular confounds. Additionally, all RSD 
research has also been limited to ex vivo preparations. Chapter 5 of this dissertation 
describes the novel finding that the in vivo, vascular retina can sustain spreading 
depression events, and that RSD in the in vivo rat occurs in response to retinal vessel 
occlusion. 
Ischemic injury in the retina 
The retina is susceptible to acute ischemic injury. Embolism of the inner retinal vessels 
can occur on either the arterial or the venous side of the circulation, and can affect the 
central retinal vessels or the branch retinal vessels. As mentioned previously, the 
primary branch vessels of the inner circulation are end-terminal vessels that do not 
anastomose. Consequently, losing perfusion of a particular vessel results in injury to all 
the tissue in that vascular territory5.  
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Clinically, venous occlusions occur more frequently than arterial occlusions, and 
occlusions of the primary branch veins of the retina are encountered most often. Many 
studies have demonstrated that the sites of retinal venous occlusions tend to be at 
arteriovenous (AV) crossings79. Primary branch retinal vessels run together and share a 
single adventitial sheath. A long-standing hypothesis proposed that occlusions at AV 
crossings might be due to compression of the flimsy venous vessel walls by thicker 
arteries, increasing turbulent flow and predisposing to thrombus formation at that site79. 
Recently, a number of reports using a variety of imaging techniques disproved this 
hypothesis, demonstrating that veins remain uncompressed at AV crossings79, 80. 
Instead, it appears that hypertrophy of the adventitial sheath encompassing the retinal 
vessels causes trophic alterations to venous endothelial cells, increasing risk of 
thrombosis at that site79. The precise mechanisms have not yet been identified. 
 
The severity of the occlusive injury generally depends on site and duration of occlusion. 
For example, higher-order branch vessels that supply a smaller territory will produce a 
smaller lesion; but if considered in functional terms, even a very small lesion may 
significantly affect vision if it occurs in the macula. Likewise, the shorter time that blood 
flow is blocked, the more likely the tissue can recover. Regardless of the site of 
occlusion, the gross histological changes in response to loss of blood flow have been 
well described. Within only minutes of occlusion, the electroretinogram (ERG) b-wave 
disappears, indicating bipolar cell dysfunction81, 82. By an hour, the retina becomes 
edematous81. This is the primary cause of initial vision loss after vessel occlusion79, 83. 
After several hours, edema peaks and particularly affects the OPL and IPL, with 
formation of vacuoles in those layers. At this time, pyknotic changes can be observed in 
the INL and GCL, indicating irreversible DNA changes in cells slated for death84. 
Degenerative changes in cellular organelles can be identified in the INL and GCL by 
electron microscopy. Cell death peaks between 6-48 hours after occlusion82. In the days 
that follow occlusion, activated microglia and infiltrating macrophages clear cellular 
debris while occluded vessels and ischemic tissues continues to undergo both necrosis 
and apoptosis82. The injury stabilizes within weeks, but residual changes are still 
present81, 83, 85. Functionally, the b-wave of the ERG remains depressed82. 
Immunohistochemical analysis reveals gliosis in the inner retina, loss of RGCs, retinal 
thinning, and Müller cell detachment from the inner limiting membrane81, 82, 85, 86.  
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These cellular changes are accompanied by a wide array of changes in gene expression 
that largely promote secondary complications of acute ischemia. Loss of blood flow 
causes hypoxia, activating hypoxia-inducible factor 1α (HIF-1α). This cascade 
upregulates vascular endothelial growth factor (VEGF) expression in the ischemic region 
along with many other pro-angiogenic genes87-89. Together, these altered protein 
expression patterns promote retinal neovascularization. Additionally, VEGF can act on 
local blood vessels to increase vascular permeability, contributing to retinal edema87. 
While increases in VEGF expression are limited to only the ischemic portion of the 
retina, changes in other edema-promoting genes occur throughout the whole retina, 
even in areas that remain perfused89. Specifically, there is a decrease in the Müller cell-
specific channels, Kir4.1 (an inwardly rectifying K+ channel) and AQP-4 (aquaporin-4)89, 
90. Müller cells play an important role in mediating K+ and water homeostasis in the 
retina. In the healthy tissue, K+ is rapidly buffered after neuronal activity, and water 
follows10, 19. The K+-water transport system is optimized by limiting Kir4.1 and AQP-4 
expression to Müller cell processes in the plexiform layers and in the endfeet close to 
blood vessels90. However, in retinal ischemia, the polarity of Kir4.1 and AQP-4 
expression is rapidly lost, and there is overall decrease in expression of these 
channels10, 90. As a result, glial water and ion transport is compromised, contributing to 
retinal edema.  
 
As discussed above, ischemic brain injury is typically associated with an increase in 
excitotoxic cell death. Likewise, glutamate-mediated excitotoxicity plays a role in retinal 
ischemic injury. There is a lot of experimental evidence that extracellular levels of 
glutamate rise during retinal ischemia5. This becomes problematic after reperfusion, 
when glutamate receptors become sensitive to glutamate again. Since neurons of the 
inner retina, including RGCs, express high levels of ionotropic glutamate receptors, they 
are more susceptible to subsequent glutamate excitotoxicity5. The hypothesis of 
glutamate-mediated cell death in the retina is supported by observations that 
exogenously added glutamate produces similar cellular changes as retinal ischemia84, 
while pharmacological blockade of glutamate signaling protects against loss of RGCs91. 
 
It would be remiss not to mention the most glaring difference between retinal and 
cerebral ischemia: the retina is significantly more resistant to acute ischemic injury than 
the brain. While the brain becomes irreversibly injured within only a few minutes, the 
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retina can remain ischemic for nearly 2 hours before cells become irrecoverable92. 
Several reasons for this have been proposed. Firstly, two vascular beds sandwich the 
retina, and loss of inner retinal blood flow may be rescued by diffusion of O2 from the 
choroid. Indeed, this hypothesis was tested to identify whether hyperoxic ventilation 
could prevent inner retinal dysfunction in retinal artery occlusion. This study found that 
choroid was unable to provide adequate oxygenation of the inner retina, even in 
hyperoxia93. Alternately, there is evidence that the retina has better sources of energy 
substrates than the brain: the vitreous contains glucose stores and glycogen, and these 
stores get depleted during ischemia94. These findings, combined with the observation 
that the retina can derive ATP under anaerobic conditions more efficiently than the 
brain5, suggest that the retinal cells can survive longer in conditions of low glucose and 
O2. Finally, the edema that accompanies ischemic injury may have more harmful 
consequences in the brain than in the retina, because cerebral swelling against the 
immovable cranium may compress additional blood vessels and limit any available 
collateral perfusion. The retina remains unbound by such physical constraints and can 
swell into the vitreous without microvascular obstruction5. 
Clinical overview of retinal vessel occlusion 
Retinal vessel occlusion accounts for the most common cause of ischemic vision loss 
after diabetic retinopathy. Clinically, retinal vessel occlusion is classified by vessel type 
(vein vs. artery) and vessel size (central vs. branch) to create four primary clinical 
categories: branch retinal vein occlusion (BRVO), central retinal vein occlusion (CRVO), 
branch retinal artery occlusion (BRAO), and central retinal artery occlusion (CRAO). 
When relevant, vessel occlusions can also be subcategorized to provide more detail 
regarding the site of occlusion (ie: optic cup vs. optic nerve head)95. Typically, vein 
occlusion is also subdivided into two categories, major or macular, to indicate embolism 
of a larger peripheral vein (major) or of a smaller branch in the macula (macular)96. The 
effort to classify retinal vessel occlusion with as much detail and precision as possible 
comes from observations that different occlusion sites carry different risk factors, 
implying that differing underlying pathological processes are responsible for retinal 
vessel occlusions at different sites. For example, age, hypertension, smoking, diabetes, 
and primary open angle glaucoma (POAG) are all risk factors for developing retinal 
vessel occlusion, but vein occlusion at AV crossings is much more likely if the patient is 
a smoker and/or hypertensive, while vein occlusion at the optic cup tends to occur more 
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often in older patients or those with a history of POAG95, and arterial occlusion is more 
likely with underlying systemic disease, such as giant cell arteritis97. These underlying 
risk factors affect prognosis and management strategies. 
 
At clinical presentation, patients typically complain of sudden onset blurring or loss of 
vision. On fundoscopic exam, the retina is edematous, the affected vessel appears 
dilated and tortuous with small hemorrhages in a flame-shaped distribution, exudates 
(areas of fluid or lipid deposition) are often appreciated, and, if the macula is not affected 
by the occluded vessel, it appears as a cherry-red spot against the edematous retina79. 
Visual acuity and peripheral vision are impaired, but degree of impairment can be quite 
variable, with a range of visual acuities at time of presentation ranging from better than 
20/40 to worse than 20/200. The initial severity of vision loss after vein occlusion may be 
a useful prognostic indicator for later visual outcomes79. A meta-analysis of vein 
occlusions reported that when initial visual acuity is worse than 20/200, vision does not 
improve for the majority of untreated patients. Similarly, the visual prognosis for BRAO 
may a better prognosis, regardless of initial acuity96 as long as the initial loss of acuity is 
not too severe98, while CRAO is associated with worse outcomes99. Over time, a 
significant proportion of patients also experience complications of vessel occlusion: (1) 
25-60% of patients develop neovascularization which contributes to vision loss by 
leading to additional hemorrhage or to retinal detachment from traction of neovascular 
outgrowths into the vitreous79; (2) chronic macular edema occurs in 60% of eyes and is 
associated with worse visual prognosis99.  
 
Treatments for retinal vessel occlusions are aimed at reducing secondary complications, 
since efficacy of thrombolysis alone has yielded conflicting data79. The two primary 
methods of intervention are (1) laser therapy and (2) intravitreal injections. Macular grid 
laser photocoagulation is a procedure that has been the clinical mainstay in treating 
macular edema for several decades. This therapy is based on the theory that the 
underlying causes of edema are leaky microaneurysms, cellular release of factors that 
promote vascular leakage (ie: VEGF, IL-1β, IL-6, etc.), and dysfunctional fluid clearance 
by retinal cells. Laser elimination of small areas of tissue in the affected area improves 
edema by coagulating leaky microvessels and reducing how many cells are secreting 
these leak factors. Reducing VEGF release also limits neovascularization. Other laser 
therapies include scatter photocoagulation for treating the peripheral retina, and 
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arteriolar constriction, a technique that partially coagulates the arteriole feeding the 
ischemic region in vein occlusion to try to limit vasogenic edema in that area.  
 
Alternately, intravitreal injections can also be used to treat edema and 
neovascularization. Specifically, intravitreal steroid injections have been shown to be 
efficacious. One study showed that intravitreal triamcinolone acetonide (TA) reduced 
macular edema and improved visual outcomes, but best results were obtained when TA 
was used in combination with macular grid laser photocoagulation100. In another study, 
intravitreal injection of dexamethasone had beneficial short-term effects, but was 
associated with a higher rate of complications when used long-term101. Finally, 
intravitreal injections of VEGF inhibitors target edema and neovascularization at the 
molecular level. Many studies have demonstrated improved visual acuity and reduced 
edema with these drugs79, 101. However, the primary disadvantage of VEGF inhibitors is 
the frequent injections patients must receive in order to continue seeing benefits. Most 
often, however, these therapies are used in combination at the discretion of the 
physician to optimize time course and combination of therapies for each patient’s 
particular clinical picture. 
 
It is important to appreciate that, as with cerebral strokes, retinal vessel occlusions have 
secondary complications that require regular intervention. In most cases, vision never 
fully recovers. Thus, there is an obvious need for additional comprehensive therapies. 
The therapeutic advantage to treating retinal vessel occlusions is that interventional time 
window may be longer than with cerebral stroke, since, as previously discussed, the 
retina is much more resistant to ischemia. The discovery of RSD (Chapter 5) offers 
exciting avenues to explore for new therapeutic strategies. 
Goals of this project 
The goals of this research were to understand the cellular consequences of acute retinal 
ischemia with the secondary goal of identifying new therapeutic targets to treat retinal 
ischemic disorders. To accomplish this, it was necessary to establish new in vivo 
imaging techniques to monitor blood flow (Chapter 3) and glial Ca2+ signaling (Chapter 
4). These methods were employed to study acute retinal ischemia and led to the 
discovery of retinal spreading depression (Chapter 5), offering new therapeutic target to 
limit ischemic vision loss. 
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CHAPTER 2: Methods 
 
 
In vivo retina preparation 
Experiments were performed on male Long-Evans rats (250–350 g). Animals were 
treated in accordance with the guidelines of the Institutional Animal Care and Use 
Committee of the University of Minnesota. The initial surgery was performed under 
isoflurane anesthesia (2% in 30% O2/70% N2, 1 L/min) introduced through a cone 
covering the mouth and nose. Depth of anesthesia was assessed periodically by paw 
pinch and depth of breathing: an appropriately anesthetized animal should not be 
responsive to any paw pinch and breathing should be deep and regular. The femoral 
vein and artery were cannulated for drug administration and monitoring of blood pres-
sure for experiments (left side for experiments described in Chapter 3, right side for 
experiments described in Chapter 5).  
 
A tracheotomy was performed to allow for mechanical ventilation of the animal during 
the experiment. The procedure begins by exposing a 2.5 cm segment of the trachea. 
The trachea was snipped perpendicularly, between two cartilage segments, and a rat 
endotracheal tube that was cut to a length of 4 cm was inserted. The tube was slid 
approximately 2.5 cm into the trachea and secured with suture. The surgical incision was 
closed and secured with staples. The animal was allowed to breathe on its own through 
the tracheal tube until all preparatory procedures are complete. The isoflurane cone was 
moved from the animal’s mouth and nose, to the tracheal tube to continue administration 
of anesthesia. 
 
The animal was wrapped in a heating blanket and placed in a modified stereotaxic frame 
with a three-point head restraint: standard ear bars and a nose clamp are attached to the 
frame, and its dimensions are 9 × 40 cm. Metal rods mounted on the two ends of the 
frame allow for the rat to be rotated around its rostral-caudal axis under the microscope 
(see Fig. 2.1A).  
 
A bolus of atropine (0.1 mg/kg) was delivered IP or IV prior beginning eye manipulations 
to counter the oculocardiac reflex, which can reduce blood pressure (see Note 2). The 
cornea and conjunctiva of the right eye were numbed with proparacaine hydrochloride  
20 
 
Figure 2.1. 
Photographs of the 
in vivo rat 
preparation. (A) Rat 
stereotaxic frame. A 
standard nose clamp 
(n) and ear bars (b) 
are mounted on a 
custom frame, which is 
attached to the 
microscope stage by 
the two rods (r) 
extending from the 
frame. The eye is 
sutured to a metal ring 
(not shown) that is 
fixed to the frame by a 
small rod (s). (B) An 
anesthetized rat, 
restrained in the 
stereotaxic frame (f), is 
attached to a movable 
stage (s) below the 
microscope. The rat 
and frame can be 
rotated around the 
long axis of the animal 
to view different 
regions of the retina. A 
hypodermic needle is 
advanced into the eye 
by a micromanipulator 
(m). (C) The eye is 
sutured to a metal ring 
(r), which is attached 
to the stereotaxic 
frame. The retina is 
viewed through a 
contact lens (c), which 
neutralizes the optics 
of the cornea. A guide 
needle (n), positioned 
by the 
micromanipulator, is 
inserted into the 
vitreous humor of the 
eye. The rat is 
ventilated via a 
tracheal tube (t). 
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(0.5% solution) and the pupil dilated with atropine sulfate (1% solution). The eye was 
sutured to a metal ring (see Fig. 2.1C) to hold it in place and allow penetration of a 
needle. A metal ring with eight holes spaced along the circumference was secured to the 
stereotaxic frame and positioned over the right eye. Working clockwise around the ring, 
the eye was secured to the ring by eight sutures through the conjunctiva. The sutures 
were tightened until the eye was held firmly without stretching or distorting the eye. One 
drop of GPS was applied to the cornea. Then, a contact lens was carefully lowered onto 
the cornea such that the anterior surface of the lens was parallel with the table and the 
posterior, concave surface of the lens was completely in contact with the GPS, without 
introducing any air bubbles (see Figs. 2.1C and 2.2A). The handle of the contact lens 
was secured to the stereotaxic frame with modeling clay. The angle of the contact lens 
could be adjusted later to maximize the retinal area being imaged (see Note 3). 
 
The stereotaxic holder was fixed to a movable stage below an upright microscope that 
served to image the retina for both laser speckle flowmetry (LSF) and confocal 
microscopy (Fig. 2.1B). The frame can be rotated along its long axis to view different 
regions of the retina. The axis of rotation is in line with the right eye of the rat so that 
when the frame is rotated, the eye remains stationary and the retina in focus.  
 
Following surgery, anesthesia was maintained for the duration of the experiment by 
continuous infusion of α-chloralose (55 mg/kg/h). A soluble form of α-chloralose (α-
chloralose-HBC-complex, Sigma; see Notes 1 and 4) was used. Animals were paralyzed 
with gallamine triethiodide (initial bolus of 20 mg/kg and continuous infusion at 20 
mg/kg/h) to prevent eye movements. Depth of anesthesia was assessed by monitoring 
heart rate and blood pressure. The heart rate increases if the animal is 
underanesthetized. From a nominal level of 90–115 mmHg, the blood pressure 
increases if the anesthetic level is too light and decreases if it is too heavy. Anesthesia 
infusion rate was adjusted accordingly (see Note 5). Core body temperature was 
monitored and maintained at 37°C (TC-1000 Temperature Controller, CWE). The animal 
was artificially ventilated (40–60 breaths/min; CWE SAR-830-P). Blood O2 saturation 
level and heart rate (MouseOx, Starr Life Sciences Corp), arterial blood pressure 
(Pressure Monitor BP-1, World Precision Instruments), and end-tidal CO2 
(microCapStar, CWE) were monitored continuously. For all experiments that did not 
involve photothrombosis, blood gases and pH were sampled periodically  
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Figure 2.2. Drawings of the in vivo rat preparation. (A) The retina is imaged through 
an upright microscope and a contact lens placed over the cornea. A hypodermic needle 
is advanced through the sclera into the vitreous humor and serves as a guide needle 
through which a smaller needle is inserted to eject dyes onto the retinal surface, or 
through which O2 sensors or recording pipettes for electrophysiology can be advanced to 
the retinal surface. Alternately, the guide needle can remain outside the globe be used to 
position an optical fiber for LSF illumination. (B) The schematic shows the optical path 
for imaging the retina with confocal microscopy while simultaneously monitoring retinal 
blood flow with laser speckle flowmetry (LSF). The retina is illuminated for LSF by 808 
nm light passing though an optical fiber that is pressed against the outer surface of the 
eye. A dichroic mirror directs the appropriate wavelengths of light from the retina to the 
LSF camera and the confocal microscope. An 808 nm bandpass filter prevents confocal 
excitation or emission light from entering the LSF camera. The confocal microscope has 
a primary scanner (488 nm) for imaging retinal vessels and a secondary scanner for 
generating 559 nm stimulating light flashes. The secondary scanner also generates 405 
nm light pulses for photolysis of caged compounds or 559 nm light pulses for activation 
of Rose Bengal for photothrombosis. See 102 for a further discussion of LSF. Modified 
from102. 
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(Instrumentation Laboratory Gem Premier 3000) and maintained within physiological 
limits (pO2: 100–125; pCO2: 35–45, and pH: 7.35– 7.45, respectively) by adjusting the O2 
level of inspired air and the ventilator breath rate and pressure (see Note 6).  
Retinal imaging 
The retina was viewed through the cornea and lens with an Olympus BX61W1 upright 
microscope and 4× and 10× dry objectives. The refractive properties of the cornea were 
neutralized by placing gonioscopic prism solution and a contact lens (5.4 mm fundus 
laser lens, Ocular Instruments) over the cornea (Fig. 2.1C and 2.2A). A CoolSnap ES 
digital CCD camera (Photometrics) was attached to the phototube of the microscope for 
LSF. The retina was imaged simultaneously with an Olympus FluoView 1000 laser 
scanning confocal microscope. Light from the retina was separated by a dichroic mirror 
(T600lpxr, Chroma Technology) in the microscope, with 808 nm light passing through to 
the LSF digital camera and 400–600 nm wavelengths reflected into the confocal scanner 
(Fig. 2.2B). An 808 nm bandpass filter was placed in front of the LSF camera to block 
residual visible wavelengths. 
Confocal microscopy 
In Chapters 3 and 4, the diameter of retinal arterioles was monitored with laser scanning 
microscopy. Blood vessels were labeled by IV injection of dextran–fluorescein 
(2,000,000 MW, 1 ml, 3% solution) and imaged with 488 nm illumination (see Fig. 2.3A). 
Alternately, dextran rhodamine B isothiocyanate dye (0.5 mL) and 559 nm illumination 
was used to image retinal vessels if glial Ca2+ was being monitored simultaneously using 
488 nm illumination (see Fig. 4.1). By using the confocal microscope in the “line scan” 
mode, both the diameter of retinal vessels102 and the velocity of red blood cells flowing 
through vessels103 can be monitored. In the resulting distance vs. time line scan images 
(see Fig. 2.3B) vessel dilation is seen as a widening of the bright lumen of the vessel.  
 
In Chapter 5, the retinal surface was imaged by reflectance microscopy with 405 nm 
illumination. For photothrombosis, Rose Bengal was administered IV (70 mg/kg bolus; 
Sigma 330000) and imaged with low intensity 559 nm illumination. Blood vessels were 
labeled by IV injection of dextran–fluorescein (2,000,000 MW, 0.3 ml, 1.5% solution) and  
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Figure 2.3. Confocal images of retinal vessels. (A) Retinal arterioles (a), venules (v), 
and capillaries are filled with dextran fluorescein isothiocyanate and imaged with 
confocal microscopy. The optic disc is at the lower left. The luminal diameter of the 
upper arteriole is measured with confocal line scans (black line). The nearby white bar 
indicates the location of the flickering light stimulus. Scale bar, 250 μm. (B) Line scan 
image obtained from the arteriole in (A). Distance (across the black line in (A)) is plotted 
as a function of time. A flickering light (white bar in (B)) evokes vessel dilation, indicated 
by the widening of the vessel cross section. The uneven edges of the vessel are caused 
by a respiratory movement artifact. Modified from 102. 
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imaged with 488 nm illumination; for assessment of vessel diameter changes, line scans 
were created post-hoc from these whole-frame images using a custom MatLab routine. 
Laser speckle flowmetry 
Retinal blood flow was monitored by LSF. The retina was illuminated with 808 nm 
infrared light from a laser diode (200 mW, L808P200, ThorLabs) and imaged with the 
digital camera. The retina was illuminated by focusing light from the laser diode onto one 
end of an optical fiber (240 μm diameter) and placing the other end of the fiber against 
the globe. The end of the optical fiber was positioned on the eye at a 35° angle from the 
horizontal, approximately 1.5 mm below the limbus. The precise position of the end of 
the optical fiber was adjusted to maximize signals from the retinal vasculature and 
minimize signals from the choroidal circulation. The infrared beam emerging from the 
optical fiber was sufficiently dim as to not cause damage to the eye and was kept on 
continuously. 
 
Images of the retina were acquired with a 30-40 ms exposure time. In preliminary 
experiments, we found that shorter exposure times reduced the speckle signals in 
smaller vessels, while longer exposure times decreased the signals in larger vessels104. 
Two-dimensional LSF images were calculated using a custom MatLab routine. Raw 
images were spatially binned into 5 × 5 pixel arrays and speckle contrast values 
computed using the following relation105,  
 
𝑆𝑝𝑒𝑐𝑘𝑙𝑒 𝑐𝑜𝑛𝑡𝑟𝑎𝑠𝑡 𝑣𝑎𝑙𝑢𝑒 =  
𝑆𝑡𝑎𝑛𝑑𝑎𝑟𝑑 𝑑𝑒𝑣𝑖𝑎𝑡𝑖𝑜𝑛 𝑜𝑓 𝑝𝑖𝑥𝑒𝑙𝑠 𝑖𝑛 𝑎𝑟𝑟𝑎𝑦
𝑀𝑒𝑎𝑛 𝑖𝑛𝑡𝑒𝑛𝑠𝑖𝑡𝑦 𝑜𝑓 𝑝𝑖𝑥𝑒𝑙𝑠 𝑖𝑛 𝑎𝑟𝑟𝑎𝑦
  
 
LSF ratio images, showing changes in blood flow produced by light stimulation, were 
computed by first averaging all speckle images acquired before a stimulus and the 
images acquired during a stimulus and dividing the latter averaged image by the former. 
Ratio images were low pass filtered to reduce noise. In ratio images, regions with values 
less than 1 (decreased speckle contrast) indicate areas of stimulus-induced increase in 
blood flow. 
 
The relative velocity of blood flow can be derived from speckle contrast values using a 
computationally intensive relation106. However, over the limited range of speckle contrast 
(Eq. 1) 
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values that we observed experimentally (0.2–0.4), relative velocity values can be 
approximated using the following relation107,  
 
𝑉𝑒𝑙𝑜𝑐𝑖𝑡𝑦  𝛼  
1
(𝑠𝑝𝑒𝑐𝑘𝑙𝑒 𝑐𝑜𝑛𝑡𝑟𝑎𝑠𝑡)2
 
 
We used this relation to compute blood velocity images from speckle contrast images. 
As above, images showing changes in blood velocity were obtained by computing blood 
velocity ratio images. Blood velocity images obtained during light stimulation were 
divided by those obtained during a pre-stimulus period. 
Light stimulation 
In Chapters 3 and 4, retinal photoreceptors were stimulated by light generated by the 
secondary (SIM) scanner of the FluoView 1000 laser scanning confocal microscope. 
Using the SIM scanner, the wavelength, intensity and scanning of a laser beam can be 
controlled independently of light from the primary scanner, which was used to acquire 
confocal and line scan images of retinal vessels.  
 
We stimulated retinal photoreceptors with a 12 Hz flickering 559 nm light of 15 s 
duration. This wavelength is near the maximal absorption wavelength of rat 
photoreceptors108 and it does not interfere with the imaging of retinal vessels, which 
utilizes 488 nm excitation and a 500–550 nm emission bandpass. The luminous flux of 
the stimulus was 0.02 lumens. A flicker frequency of 12 Hz was chosen because it 
produces a maximal functional hyperemia response in many species109. A flicker rate of 
12 Hz with a duty cycle of 50% was generated by scanning a 135 by 20 μm region of the 
retina with the secondary confocal scanner. With a pixel dwell time of 100 μs, this 
elongated horizontal rectangle was scanned downwards in 42 ms. At the end of the 
scan, the 559 nm light was blanked and the beam returned to the top of the rectangle. 
The return scan took an additional 42 ms. When the scan is repeated continuously, a 
flickering 12 Hz light is produced. Although the dimensions of the scanned rectangle 
were chosen to generate the appropriate stimulus frequency, the rectangular region is 
sufficiently small compared to the overall size of the retina to be useful for mapping 
localized hemodynamic responses. 
 
(Eq. 2) 
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Retinal photoreceptors were also stimulated with a 12 Hz diffuse white light having a 
luminous flux of 1.9 lumens falling on the eye. Light from a fiber optic illuminator was 
gated with an electromechanical shutter and focused onto the eye through a fiber 
bundle. This light effectively stimulated the entire retinal surface. 
Labeling and stimulating glial cells 
The Ca2+ indicator dye Oregon Green 488 BAPTA-1AM (OGB) was used to label glial 
cells (see Note 7). The labeling solution was prepared immediately before use by mixing 
3 μL OGB (300 μg/mL) with 1 μL pluronic F-127 (7 mg/mL), 3 μL serine (100 μM), and 
25 μL saline (see Note 8). For experiments where glial cells were stimulated, 3 μL of the 
caged Ca2+ compound NP-EGTA was included in the labeling solution.  
 
Prior to labeling, the vitreous humor was digested by enzymatic treatment with 
hyaluronidase to achieve efficient retinal glial cell labeling. 10 μL of hyaluronidase in 
saline (125 U/10 μL) was loaded into a Hamilton syringe attached to a 31-gauge needle. 
The needle was inserted into a 25-gauge guide needle until the tip of the inner needle 
was in line with the tip of the guide needle. With the animal mounted under the 
microscope, the guide needle was inserted through the sclera and into the vitreous 
humor at a 35° angle from the horizontal, approximately 1.5 mm below the limbus. Once 
the 25-gauge guide needle had passed through the sclera and retina, the 31-gauge 
needle was advanced through the guide needle until it was touching the surface of the 
retina (see Fig. 2.2A). The needle was positioned under confocal observation using 
reflected light to view the retina. The hyaluronidase solution was injected onto the 
surface of the retina at several locations. The needle was then withdrawn from the 
surface and the preparation was maintained for 1–2 h as the hyaluronidase broke down 
the hyaluronic acid of the vitreous humor. After the rest period of 1–2 h, the labeling 
solution was injected into the vitreous humor. 10 μL of the labeling solution was loaded 
into the same 31-gauge needle attached to the Hamilton syringe, which had been 
withdrawn from the 25-gauge guide needle. The 31-gauge needle was reinserted into 
the guide needle, which had remained in the eye. The labeling solution was injected into 
the vitreous humor near the retinal surface. Good labeling of glial cells was achieved 60–
90 min after injection of the solution. The dye and caged Ca2+ compound were taken up 
selectively by the glial cells of the retina110 (see Fig. 4.1).  
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Glial cells were stimulated by photolysis of caged Ca2+ with 405 nm light (see Note 9). 
The uncaging light was generated by the SIM scanner of the confocal microscope and 
was focused onto a small 5–10 μm spot on the retinal surface using the tornado scan 
mode of the SIM scanner (see Note 10). A 10 ms to 1 s pulse of 405 nm light was 
sufficient to generate a large Ca2+ increase in the stimulated cells (see Fig. 4.2A). 
Photolysis of caged Ca2+ often evoked a propagated Ca2+ wave that traveled into 
adjacent glial cells.  
Photothrombosis 
In Chapter 5, photoactivation of Rose Bengal for photothrombosis was achieved using 
the SIM scanner’s 559 nm laser. The “tornado” bleach setting was used to focus light 
onto a ~20 μm area on a primary retinal vessel.  
Electrophysiology 
Extracellular recordings of retinal ganglion cell (RGC) activity and the DC potential were 
conducted in ex vivo eyecup and in vivo preparations. Eyecups were prepared as 
previously described111. Briefly, eyes from 2-3 month old male Long Evans rats were 
bisected at the equator and everted over a dome in a custom superperfusion 
chamber111. The eyecup was superfused at 2-3 ml/min with bicarbonate Ringers solution 
bubbled with carbogen at 33 deg C. Retinas were imaged by reflectance microscopy 
with a confocal microscope (Olympus FV1000) and a 10X water immersion objective. 
Recording pipettes (~10 µm tip diameter) were filled with bicarbonate Ringers and 
advanced into the RGC layer. Signals were band-pass filtered (156 – 1800 Hz) to record 
RGC spike activity and low-pass filtered (0.2 Hz) to record DC potentials. K+ gluconate 
ejection pipettes were filled with 150 mM K+ gluconate and positioned just above the 
retinal surface at the periphery of the eyecup. For OGD experiments, eyecups were 
superfused with OGD Ringers solution.  
 
For in vivo electrophysiology experiments, recording pipettes (~0.5 µm tip diameter) 
were filled with 3 M NaCl. Pipettes were advanced though the sclera and vitreous within 
a 25 gauge guard needle attached to a custom microadvancer112. The pipette was 
advanced ~10 µm into the retina. Signals were low-pass filtered (0.5 Hz) to record DC 
potentials. 
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Oxygen partial pressure 
O2 tension at the surface of the retina was measured with a custom optical O2 probe 
(OxyLite NX pO2 Bare Fiber Beveled Sensor; Oxford Optronix Ltd.) that was advanced 
through the sclera and vitreous humor inside a 25 gauge guard needle. The O2-sensitive 
tip of the probe was beveled so that it lay flat against the surface of the retina when it 
was in place. Control experiments demonstrated that the photothrombosis bleaching 
light did not interfere with O2 measurements.  
Red blood cell flux  
Red blood cell (RBC) flux through arterioles was measured as previously described113. 
Briefly, blood was withdrawn from the animal at the beginning of an experiment and 
RBCs were isolated and incubated for 5 min in the fluorescent lipophilic dye DiD 
(carbocyanide 1,1’-dioctadecyl-3,3,3’,3’-tetramethylindodicarbocyanide,4-
chlorobenzenesulfonate salt solid; Invitrogen; #D-7757). Cells were washed to remove 
unbound dye and reinjected into the animal. Fluorescent RBCs were imaged with 635 
nm confocal line scans oriented perpendicular to the vessel lumen. Line scans were 
acquired at 4200 Hz and labeled RBCs detected by a custom MatLab routine. 
Immunohistochemistry 
A modified in vivo preparation was adopted to permit animal survival following thrombus 
formation. Animals were anesthetized with 2% isoflurane and the tail vein cannulated for 
delivery of alpha chloralose anesthetic and Rose Bengal dye. Animals breathed a 
mixture of 30% O2 and 70% nitrogen. O2 saturation was monitored by pulse oximetry to 
ensure adequate ventilation. Following 60 minutes of photothrombosis, the animal 
recovered from anesthesia. Animals were sacrificed after 14 days and the retina was 
removed from the experimental eye and fixed in 4% paraformaldehyde for 2 hours. 
Retinas were immunolabeled for the RGC marker Brn3a with primary goat antibodies 
(1:500; 24 hours; sc-31984, Lot # L2414; Santa Cruz Biotechnology) and Alexa Fluor 
488 donkey anti-goat secondary antibodies (1:500; 2 hours; A11055; Lot # 1369678; Life 
Technologies) as previously described114. The retinal vasculature was labeled with 
Isolectin GS-IB4-647 (1:75; 2 hours; Invitrogen I32450). Retinas were imaged with 
confocal microscopy. To confirm loss of RGCs, retinas were also imaged with infrared 
differential interference contrast microscopy. 
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Solutions 
All pharmacological agents that were injected i.v. during in vivo experiments were 
dissolved in medical grade saline. Bicarbonate Ringers solution used in eyecup 
exeriments contained, in mM: 111 NaCl, 3.0 KCl, 2.0 CaCl2, 1.0 MgSO4, 0.5 NaH2PO4, 
15.0 dextrose, 32 NaHCO3 (bubbled with 95% O2 and 5% CO2, pH 7.4). OGD Ringers 
solution contained, in mM: 111 NaCl, 3.0 KCl, 2.0 CaCl2, 1.0 MgSO4, 0.5 NaH2PO4, 15.0 
sucrose, 32 NaHCO3 (bubbled with 95% N2 and 5% CO2, pH 7.4). 
Image processing 
LSF images were analyzed using a custom MatLab routine as previously described102. 
Ratio speckle images were calculated by first averaging all speckle images acquired 
before vessel occlusion and the images acquired during occlusion and dividing the latter 
by the former. Vessel diameter measurements were analyzed from confocal line scans 
using a custom MatLab routine. Alternately, line scans were created from confocal 
images post-hoc and analyzed using a different custom MatLab routine. RSD waves 
were analyzed from reflectance intrinsic optical signal (IOS) images using a custom 
MatLab routine. IOS images were acquired at 0.61 Hz. Δ intensity/intensity IOS images 
were calculated by low pass filtering each frame to reduce noise, then subtracting from 
each frame the mean of the preceding 20 frames and then dividing that difference by the 
mean. These images highlighted the leading edge of the RSD waves. Matlab routines 
also calculated the radius and velocity of RSD waves based on a user-specified 
identification of wave origin and the distal extent of the wave. RBC flux confocal line 
scan images were analyzed using a custom MatLab routine as previously described113.  
Statistics 
Data are presented as mean ± SEM. Comparisons between two groups were performed 
using two-tailed Student’s t-test. The parametric version of the test was chosen when 
variances were equal between groups, while the non-parametric version of the test was 
chosen for groups with unequal variances. When multiple groups were compared to the 
same control, statistical differences were calculated using an ANOVA with a post-hoc 
Dunnett’s correction. Calculations were carried out in Excel (2013) or GraphPad Prism 
(version 5.04). 
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Notes 
1. α-Chloralose HBC complex, rather than uncomplexed α-chloralose, is used, as 
the HBC complex of α-chloralose is fully soluble in water while uncomplexed 
chloralose is difficult to solubilize. Chloralose concentrations are specified for the 
molecular weight of the α-chloralose HBC complex, which is ten times the 
molecular weight of the uncomplexed α-chloralose. 
2. The oculocardiac reflex is triggered by pressure on the eyeball or traction on the 
extraocular muscles and results in a decrease in heart rate and blood pressure. 
The reflex is a parasympathetic response mediated by the trigeminal and vagus 
nerves. It can be prevented by intravenous injection of the muscarinic antagonist 
atropine, which blocks the vagal reflex. 
3. The GPS solution sometimes leaks out from under the contact lens during the 
course of an experiment. If this occurs, the contact lens is removed, more 
solution added to the cornea, and the contact lens replaced. Alternately, 
additional GPS solution can be injected under the contact lens using a syringe 
with a 25-gauge needle. 
4. The choice of anesthetic is critical when characterizing vascular responses. 
Some anesthetics suppress the functional hyperemia response while α-
chloralose leaves the response largely intact115. 
5. It is particularly important to maintain blood pressure within the normal range 
when characterizing vascular responses. If blood pressure drops below the 
physiological range, the diameter of retinal arterioles oscillates and the functional 
hyperemia response is lost. 
6. It is critically important to maintain blood gases within the physiological range 
when characterizing vascular responses. High pO2 results in attenuation of light-
evoked vasodilation while low pO2 leads to vessel oscillations and a loss of light-
evoked dilation. A pulse oximeter can be used to continuously monitor blood O2 
saturation, which gives an estimate of blood pO2 levels. Blood pH is also 
important. If the pH falls outside the normal range, either high or low, light-
evoked vasodilations are attenuated or are eliminated and vessels may oscillate. 
pCO2 is directly linked to pH and can be monitored continuously by measuring 
end-tidal CO2 levels. 
7. The Ca2+ indicator dye Fluo-4 is often used to measure glial Ca2+ and was used 
previously to monitor Ca2+ levels in the isolated retina preparation116. However, 
32 
 
we find that Fluo-4 is ineffective in labeling retinal glial cells in vivo while OGB 
labels both astrocytes and Müller cells. OGB has a higher Ca2+ affinity than does 
Fluo-4 (Kd of 170 vs. 345 nM) and this may account for the difference in labeling. 
8. Pluronic F-127 facilitates the uptake of OGB and NP-EGTA into retinal glial cells. 
Eserine inhibits esterases in the vitreous humor and prevents cleavage of the AM 
ester groups of OGB and NP-EGTA until it enters the glial cells117. 
9. 405 nm light, rather than UV light (normally employed for photolysis of caged 
compounds), is used in this preparation for several reasons. First, the plastic 
contact lens and the lens of the eye are transparent at 405 nm but not at UV 
wavelengths. Second, confocal microscopes are typically equipped with 405 nm 
but not UV lasers. Third, the optics of the SIM scanner of the Olympus FV1000 
microscope is not compatible with UV wavelengths. 
10. Due to chromatic aberration of the eye, 405 nm light projected onto the retina is 
distorted. A 5 μm spot will be blurred to a circle ~40 μm in diameter. In addition, 
the spot will be displaced laterally if the illumination is off axis. 
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CHAPTER 3:  
Imaging retinal blood flow with laser speckle 
flowmetry 
 
 
Summary 
Laser speckle flowmetry (LSF) was initially developed to measure blood flow in the 
retina. More recently, its primary application has been to image baseline blood flow and 
activity-dependent changes in blood flow in the brain. We now describe experiments in 
the rat retina in which LSF was used in conjunction with confocal microscopy to monitor 
light-evoked changes in blood flow in retinal vessels. This dual imaging technique 
permitted us to stimulate retinal photoreceptors and measure vessel diameter with 
confocal microscopy while simultaneously monitoring blood flow with LSF. We found that 
a flickering light dilated retinal arterioles and evoked increases in retinal blood velocity 
with similar time courses. In addition, focal light stimulation evoked local increases in 
blood velocity. The spatial distribution of these increases depended on the location of 
the stimulus relative to retinal arterioles and venules. The results suggest that capillaries 
are largely unresponsive to local neuronal activity and that hemodynamic responses are 
mediated primarily by arterioles. The use of LSF to image retinal blood flow holds 
promise in elucidating the mechanisms mediating functional hyperemia in the retina and 
in characterizing changes in blood flow that occur during retinal pathology. 
Introduction 
Laser speckle flowmetry (LSF) has been successfully employed to measure blood flow 
in the CNS for three decades. It has the distinct advantage over other methods of 
monitoring blood flow, such as laser Doppler flowmetry, as it can produce two-
dimensional images of blood flow with high spatial and temporal resolution. 
 
The principals underlying LSF have been described in detail elsewhere104-106. Briefly, 
when an optically rough surface is illuminated with coherent light, a speckle pattern is 
produced as the incident light is reflected off of surfaces lying at different depths. Some 
areas of the surface appear bright due to constructive interference while other areas 
appear dark due to destructive interference. If the surface is stationary, the speckle 
pattern of bright and dark spots will remain stationary as well. However, if the surface 
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moves (e.g., blood cells moving through vessels), the speckle pattern will blur with time. 
Thus, a stationary region on the surface will have a high speckle contrast while a moving 
region will have a low speckle contrast when imaged over the appropriate time 
window104. In practice, local speckle contrast is calculated by imaging a surface with a 
digital camera and computing the standard deviation of brightness divided by the mean 
brightness over a small array of pixels. The resulting speckle contrast value is used to 
evaluate relative velocity. With modern computational techniques, speckle contrast can 
be calculated and speckle images analyzed almost instantaneously. 
 
Although LSF has been used in many studies to monitor blood flow in the cortex118-120, 
the very first use of LSF was to monitor blood flow in the retina. The first studies106, 121 
were conducted in the early 1980s, before it was practical to calculate speckle contrast 
with digital techniques. Instead, the retina was imaged on film and speckle contrast 
images were obtained with high-pass spatial filtering optical techniques. The resulting 
images displayed patterns of blood flow in the human retina, with arterioles and venules 
highlighted because the velocity of blood flow was greatest in these vessels. 
 
More recently, LSF has been used to monitor blood flow in the retina using digital 
cameras and computational techniques to calculate speckle contrast images. Retinal 
vessels have been imaged in rabbit122 and rat123 retinas and changes in blood flow have 
been monitored in response to varying intraocular pressure and varying levels of 
inspired O2. LSF has also been employed to investigate the effects of glaucoma 
therapies on retinal circulation in rabbits124, monkeys125, and people126 and to monitor the 
choroidal circulation in patients with polypoidal choroidal vasculopathy127. 
 
We now describe results obtained using LSF to image blood flow in the in vivo rat retina. 
The goals of this project were twofold. First, we wanted to develop a technique to 
combine LSF with laser scanning confocal microscopy of the retina. This would allow us 
to monitor spatial and temporal patterns of retinal blood flow with LSF while 
simultaneously monitoring the diameter of retinal vessels with confocal line scans. An 
added benefit of this technique is that a second channel of the confocal microscope can 
generate spatially and temporally defined visual stimuli to activate retinal photoreceptors. 
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The second goal of this project was to determine whether blood flow is regulated at the 
local level in the retina. In the brain, localized increases in neuronal activity lead to 
spatially restricted increases in blood flow128. This hemodynamic response, termed 
functional hyperemia, supplies active neurons with needed O2 and nutrients. Previous 
work using laser Doppler flowmetry and other techniques109 has shown that global 
stimulation of the retina results in global increases in retinal blood flow. In addition, an 
fMRI study has demonstrated that when one-half of the retina is stimulated with light, 
blood flow increases in that half, but not the other half of the retina129. However, fMRI 
does not currently have the resolution to accurately determine the spatial extent of the 
functional hyperemia response in the retina. Laser speckle flowmetry, in contrast, is 
ideally suited to mapping the spatial extent of blood flow increases evoked by focal 
stimulation105, 119. 
 
We describe in this report methods for successfully combining LSF and laser scanning 
confocal microscopy to monitor blood flow in the retina of the anesthetized rat. With this 
combined imaging system, we use confocal microscopy to stimulate photoreceptors in 
restricted retinal regions while simultaneously monitoring arteriole diameter with confocal 
line scans. At the same time, we use LSF to visualize spatial patterns of blood flow 
changes. We find that, as in the brain, focal stimulation of retinal photoreceptors does 
indeed produce localized increases in blood flow in the retinal circulation. Spatial 
patterns of functional hyperemia responses suggest that blood flow is regulated primarily 
by first and second order arterioles in the retina, but not by capillaries or venules. 
Results 
Simultaneous confocal and LSF imaging of the retina 
We imaged the retina through the cornea and lens using an upright microscope though 
which confocal and laser speckle images were obtained simultaneously. The refractive 
properties of the cornea were neutralized with a contact lens placed between the eye 
and the microscope objective lens (Fig. 2.2A). For LSF, the retina was illuminated with 
808 nm infrared light (Fig. 2.2B). This wavelength is well outside the absorption range of 
photoreceptor photopigments108. Thus, retinal photoreceptors and neurons were not 
stimulated by the LSF illumination light. 
 
Arterioles and venules, which radiate from the optic disc, can be visualized 
simultaneously by confocal microscopy and LSF. This is illustrated in Fig. 3.1, where a 
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confocal image of retinal vessels is shown in Fig. 3.1A, a raw laser speckle image 
acquired simultaneously in Fig. 3.1B, a computed laser speckle contrast image in Fig. 
3.1C and a computed blood velocity image in Fig. 3.1D. In the confocal image (Fig. 
3.1A), primary arterioles and venules, filled with fluorescent dye, radiate from the optic 
disc at the bottom left. Arterioles can be distinguished from venules by their smaller 
diameter. Secondary and tertiary arterioles, branching from the primary vessels, are 
clearly seen in this image, as are retinal capillaries. In the raw speckle image (Fig. 3.1B), 
the larger vessels are seen as regions of reduced speckle contrast. They appear 
smoother than surrounding retinal areas, which are more speckled. When a speckle 
contrast image (Fig. 3.1C) is computed from the raw image, the larger vessels appear 
darker. This is because blood is flowing more rapidly through the larger vessels, 
resulting in blurring of the speckles and lowering of the speckle contrast. Computed 
speckle contrast (Chapter 2, Eq. 1) is invariant with incident illumination. Thus, the 
intensity of the speckle contrast image (excluding the major vessels) is relatively 
uniform, even though the intensity of the raw speckle image (Fig. 3.1B) varies greatly. 
When a blood velocity image (Fig. 3.1D) is computed from the speckle contrast image, 
vessels with high blood velocity appear brighter. Blood velocity is roughly proportional to 
pixel intensity in this image and is greatest in the primary arterioles and venules. 
Illumination of the retina 
The LSF in the retina has previously been achieved using a custom fundus camera that 
allows on-axis illumination of coherent light that passes through the cornea and lens122. 
However, when using an upright microscope to obtain simultaneous LSF and confocal 
images, on-axis illumination is difficult to implement in practice. Reflection of the coherent 
light off of the microscope lenses and the contact lens produces strong interference 
patterns which obscure portions of the LSF images. 
 
Instead of using on-axis illumination, we have employed an off-axis method of 
illumination. Light from an 808 nm laser diode is directed through an optical fiber and 
onto the sclera at the appropriate position and angle to illuminate the retinal area being 
imaged (Fig. 2.2B). Sufficient light passes through the sclera and the retinal pigment 
epithelium to illuminate the retina. This trans-scleral illumination pathway is aided by the  
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Figure 3.1. Laser speckle flowmetry of retinal blood vessels. (A) Confocal image of 
retinal blood vessels labeled with dextran-fluorescein. Primary arterioles and venules are 
seen radiating from the optic disc (at the lower left). (B) Raw speckle image acquired 
simultaneously from the same retina as (A). Note that there is less speckling in the 
regions corresponding to the major vessels. (C) Speckle contrast image calculated from 
(B). Dark lines indicate regions of reduced speckle contrast, generated by blood flowing 
rapidly through the primary retinal vessels. (D) Blood velocity image calculated from (C). 
The brighter areas indicate greater blood velocity. In this and subsequent figures, 
primary arterioles and venules are labeled “a” and “v,” respectively. Scale bar for all 
panels, 250 μm.  
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use of infrared light, which passes through tissue more easily than does visible light. 
Depending on the precise position of the optical fiber illuminating the globe, either the 
retinal vasculature or the choroidal circulation is imaged. When the optical fiber is 
positioned 1–2 mm posterior to the limbus, the retinal circulation is visualized (Fig. 3.2A). 
The pattern of arterioles and venules corresponds to the fluorescence confocal image of 
the fluorescein-filled vessels (Fig. 3.2B). In some preparations, indistinct splotches, as 
well as the retinal vessels, are seen in speckle contrast and blood velocity images (Fig. 
3.2A, arrowheads). These splotches are out of focus choroidal vessels. As the focus is 
shifted to the plane of the choroid and the end of the illuminating fiber is moved towards 
the posterior pole of the globe, the choroidal circulation becomes more distinct (Fig. 
3.2C). The splotches seen in images of the retinal vessels correspond to the larger 
choroidal vessels (Fig. 3.2C, arrowheads). Although LSF images of choroidal vessels 
are of reduced quality, one must bear in mind that the vessels are imaged through 350 
μm of tissue and a heavily pigmented layer, the retinal pigment epithelium. The size and 
branching patterns of the choroidal vessels imaged with LSF resemble those seen in 
corrosion casts of the choroidal vasculature (Fig. 3.2D). 
Light-evoked changes in arteriole diameter 
We monitored light-evoked changes in retinal circulation using both confocal microscopy 
and LSF. Retinal arterioles dilate in response to light stimulation109. This dilation can be 
quantified with confocal line scans. A line oriented perpendicular to an arteriole (Fig. 
3.3A, yellow line) is repeatedly scanned for the duration of a trial. The resulting line scan 
image (Fig. 3.3B) displays the vessel diameter as a function of time. When retinal 
photoreceptors are stimulated (Fig. 3.3B, white bar), the vessel dilates. A plot of vessel 
diameter vs. time (Fig. 3.3D, trace 2) shows that light evokes a rapid increase in vessel 
diameter with a latency of approximately 1 s. Typically, a flickering light evoked a 
biphasic response consisting of a transient dilation lasting around 5 s followed by a 
sustained increase in vessel diameter. In a series of trials, vessel dilation averaged 8.87 
± 0.71% (S.E.M.; n = 60, six animals) of baseline diameter. Latency to the onset of 
dilation (time to 50% peak amplitude) was 1.51 ± 0.06 s (n = 52, six animals). 
 
Changes in blood velocity were monitored simultaneously with vessel diameter using 
LSF. Hemodynamic responses were analyzed by calculating blood velocity images from  
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Figure 3.2. Laser speckle flowmetry of the retinal and choroidal vasculature. (A) A 
blood velocity image of retinal vessels. In addition to the primary arterioles and venules, 
indistinct splotches (arrowheads), which are generated by choroidal vessels, are seen. 
(B) Confocal image of the retinal vasculature from the same retinal region as (A). (C) A 
blood velocity image of choroidal vessels in the same preparation as (A) and (B). The 
image was obtained by adjusting the focal plane of the microscope and moving the 
illuminating optical fiber toward the posterior pole of the globe. The splotches visible in 
(A) correspond to major choroidal vessels (arrowheads) visible in (C). (D) A corrosion 
cast of the choroidal vasculature of the rat, reproduced at the same magnification as the 
other panels. Note that the size and branching patterns of the vessels are similar to 
those in (C). From 130, used with permission. Scale bar for all panels, 250 μm. 
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Figure 3.3. Light-evoked changes in retinal blood flow measured with confocal 
microscopy and LSF. (A) Confocal image of retinal vessels. The diameter of the upper 
arteriole was measured with confocal line scans (yellow line). The nearby white bar 
indicates the location of the flickering light stimulus in panels (A) and (C). Scale bar for 
panels (A) and (C), 250 μm. (B) Line scan image obtained from the arteriole in (A). 
Distance [across the yellow line in (A)] is plotted as a function of time. A flickering light 
[white bar in (B)] evokes vessel dilation, indicated by the widening of the vessel cross 
section. The uneven edges of the vessel are caused by a respiratory movement artifact. 
(C) Blood velocity ratio image, showing the light-evoked change in velocity, calculated at 
2–5 s after onset of the stimulus. The flickering light evoked large blood velocity 
increases in the two primary arterioles and smaller increases in the venules. (D) Time 
course of the light-evoked responses. (Trace 1) Change in arteriole diameter [measured 
at the yellow line in (A)] evoked by the onset of the 488 nm line scan excitation light, at 
the beginning of the trace. The flickering light stimulus was not turned on. The small 
response decayed within 10 s. (Trace 2) The same conditions as trace 1, except that the 
flickering light stimulus (black bar at bottom) was turned on. (Trace 3) change in blood 
velocity within the same arteriole, measured in the rectangular region indicated in (C). 
Changes in light-evoked arteriole diameter and blood velocity were similar.  
41 
 
raw speckle images using equations 1 and 2 (Chapter 2). Changes in blood velocity 
were visualized by calculating blood velocity ratio images. Averaged velocity images 
obtained during the transient phase of the light response (2–5 s following stimulus onset) 
were divided by the averaged images obtained prior to stimulation. Six to 15 ratio 
images from sequential trials were averaged together to improve signal to noise. In 
these averaged pseudocolor ratio images, increased blood velocity is indicated by 
yellows, reds and white. The velocity ratio image for the trial illustrated in Fig. 3.3C, 
shows a prominent light-evoked increase in blood velocity in the primary arteriole 
adjacent to the stimulus as well as in a neighboring primary arteriole. Smaller velocity 
increases are seen in the primary venules. The time course of velocity within one of the 
arterioles (measured within the boxed area in Fig. 3.3C) is illustrated in Fig. 3.3D, trace 
3. It has a similar time course to the dilation measured in the same vessel (Fig. 3.3D, 
trace 2). 
 
Line scan measurements of arteriole diameter were made using 488 nm light, which 
stimulates retinal photoreceptors as well as exciting the dye used to image vessels. 
Although the intensity of the 488 nm light was far dimmer (typically 400-fold) than the 
559 nm light used to stimulate retinal photoreceptors, onset of the line scan light did, in 
many trials, evoke a vascular response. However, as shown in Fig. 3.3D, both the 
increase in vessel diameter (trace 2) and the increase in blood velocity (trace 3) evoked 
by the onset of the line scan light were substantially smaller than the responses evoked 
by the 559 nm flickering stimulus. In addition, the response to the onset of the line scan 
light decayed rapidly (Fig. 3.3D, trace 1), well before the flickering stimulus was turned 
on. It should be noted that the 488 nm light was not turned on when only blood velocity, 
and not vessel diameter, was monitored (Fig. 3.4). 
Light-evoked changes in blood flow 
Increases in blood flow evoked by retinal stimulation have been characterized using a 
number of techniques109. However, the spatial extent of these increases has not 
previously been determined. It is not known, for instance, whether a spatially restricted 
light stimulus will evoke a localized increase in blood flow or whether the increase will 
spread far beyond the illuminated region. 
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Figure 3.4. Blood velocity increases evoked by focal and diffuse light stimulation. 
Each row in the figure represents a different stimulus condition. Top three rows, the 
retina was stimulated with a focal, 15 s flickering light. Bottom row, the retina was 
stimulated with a diffuse 15 s flickering light. The left panels of each row show confocal 
images of the retina. Scale bars (at the bottom right of each panel), 250 μm. The middle 
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(Figure 3.4, cont.) panels show blood velocity ratio images for the same retinal regions. 
The pseudocolor images show the change in blood velocity at 2–5 s after stimulus onset 
and the pseudocolor scale bars indicates Δ velocity in percent. The locations of the large 
vessels are indicated by black lines. The small white bars in the left and middle panels 
indicate the locations of the focal stimulus. The right panels show the time course of 
blood velocity changes evoked by the light stimulus (black bars below the traces) for 
selected retinal regions. The region where each measurement was made is indicated by 
the numbers in the middle panels. Except when otherwise noted, blood velocity was 
measured within arterioles or venules. (A–C) The retina was stimulated near a branch 
point of first and second order arterioles. Blood velocity was measured in a non-
stimulated arteriole (1), a venule (2), and the stimulated arteriole (3). Increased blood 
velocity was greatest within and in the regions immediately surrounding the stimulated 
arteriole. (D–F) The stimulus was near a third order arteriole. Blood velocity was 
measured in a venule (1), the stimulated third order arteriole (2), and the upstream first 
order arteriole (3). Increased blood velocity was greatest within the stimulated third order 
arteriole. (G–I) The stimulus was in a capillary bed, near a first order venule. Blood 
velocity was measured in the stimulated venule (1), a 200 μm diameter region 
surrounding the stimulus (2), and a distant arteriole (3). Increased blood velocity was 
small in the stimulated region and nearby venule but much larger in the arteriole. (J–L) 
The retina was stimulated uniformly by a diffuse light. Blood velocity was measured in an 
arteriole (1), across the entire imaged region of the retina (2), and a venule (3). 
Increased blood velocity was greatest in the primary arterioles and in regions supplied 
by arteriole branches.We have now characterized retinal blood flow responses to focal 
stimulation using a combination of LSF and confocal microscopy. We stimulated retinal 
photoreceptors with a 559 nm, 12 Hz flickering light generated by the confocal 
microscope. This stimulus illuminated a 135 × 20 μm region on the retinal surface (see 
Chapter 2). Changes in blood velocity evoked by this stimulus were monitored with LSF 
using 808 nm illumination. 
 
 
We found that the spatial pattern of blood velocity increase evoked by this focal stimulus 
varied depending on the location of the stimulus relative to retinal arterioles and venules. 
When the stimulus was near a primary arteriole, increased blood velocity was greatest in 
that arteriole and in the region immediately surrounding the vessel (Fig. 3.4B). In many 
cases, other nearby primary arterioles also showed large velocity increases (Figs. 3.3C 
and 3.4B). The time course and amplitude of the velocity increase was calculated for 
regions corresponding to the stimulated primary arteriole and nearby arterioles and 
venules. Light-evoked velocity increases in the arterioles and venules typically had similar 
time courses (Fig. 3.4C), but the velocity increases in the arterioles were larger than were 
the increases in the venules (Fig. 3.5). The peak velocity increase in the stimulated primary 
arteriole averaged 7.60 ± 0.83% (n = 10, seven animals) and had a latency of 1.49 ± 0.12 
s (n = 9, six animals). The amplitude of  
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Figure 3.5. Amplitude and latency of blood velocity increases measured with LSF. 
Shown are mean response amplitude (peak change in blood velocity) and latency (time 
to 50% peak amplitude) for responses evoked under three different stimulus conditions: 
a focal stimulus near a primary arteriole, a focal stimulus far from 1°, 2°, or 3° arterioles, 
and a diffuse stimulus. Blood velocity was measured within primary arterioles (back 
bars), within primary venules (open bars), and, for diffuse stimulation, over the entire 
visible retina (gray bars). Error bars, S.E.M. 
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the velocity increase in the adjacent primary venule was smaller, averaging 2.44 ± 0.48%, 
with a latency of 1.95 ± 0.22 s (n = 6, four animals).  
 
When the focal stimulus was near a second or third order arteriole, increased blood 
velocity was seen within the stimulated vessel and in upstream arterioles serving the 
vessel (Fig. 3.4E). The time course of the velocity increase was similar in the stimulated 
vessel and in upstream vessels. However, the observed temporal similarity of these 
responses may be due to the fact that our sampling rate (4 Hz) was not fast enough to 
detect small changes in response latency. It should also be borne in mind that when an 
increase in blood velocity is observed within a vessel, that increase could be due to 
active dilation of that vessel or to dilation of upstream arterioles, causing an increase in 
the pressure head to the vessel. 
 
Blood velocity increases were somewhat smaller when the focal stimulus was distant 
from first, second, and third order arterioles (Figs. 3.4G and 3.5). In these cases, the 
largest velocity increases were seen in primary arterioles, even though they were some 
distance from the stimulus (Figs. 3.4H,I, trace 3). Responses were smaller in venules 
and in regions near the stimulus (Figs. 3.4H,I, traces 1 and 2). Peak blood velocity 
increases in the primary arteriole nearest to the stimulus averaged 6.47 ± 0.85% (n = 10, 
seven animals) and had a latency of 1.42 ± 0.10 s (n = 10, seven animals). Responses 
in the nearest primary venule averaged 2.07 ± 0.54% (n = 10, seven animals) and had a 
latency of 1.58 ± 0.21 s (n = 8, six animals). Responses averaged 2.08 ± 0.59% (n = 10, 
seven animals) and had a latency of 1.22 ± 0.21 s (n = 5, five animals) in a region 200 
μm in diameter centered on the stimulus. We also measured the amplitude of blood 
velocity increase in an annular region 200–400 μm from the stimulus to determine 
whether the local response was restricted to the area of stimulation. The velocity 
increase in this annular region was 2.25 ± 0.60% (n = 10, seven animals), not 
significantly different from the response in the 200 μm diameter region centered on the 
stimulus. 
 
Activation of a local region of the cerebral cortex sometimes evokes decreased blood 
flow in regions distant from the central region of increased blood flow131, 132. In our retinal 
experiments, we never observed a consistent decrease in blood velocity in response to 
focal light stimulation, regardless of the location of the stimulus. However, such a 
decrease could have occurred outside the field of view of our imaging system. 
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A diffuse flickering white light also evoked increased retinal blood velocity. As expected, 
blood velocity increases were more uniformly distributed across the retina (Fig. 3.4K) 
than were increases evoked by focal stimulation. Velocity increases were larger in some 
retinal regions than others. These regions were generally associated with second and 
third order arterioles (Fig. 3.4K). Velocity increases were greatest in primary arterioles 
(11.74 ± 1.91%; latency; 1.30 ± 0.05 s, n = 8, five animals; Fig. 3.5) as well as in regions 
near primary and secondary arterioles. Increases were substantially smaller in primary 
venules (3.41 ± 0.68%, n = 8, five animals; latency; 1.36 ± 0.11 s, n = 6, four animals). 
Blood velocity increases averaged over the entire viewable retina equaled 6.31 ± 1.23% 
(n = 8, five animals; latency; 1.26 ± 0.09 s, n = 7, five animals) (Fig. 3.4L, trace 2). 
Discussion 
We have described methods for combining LSF and laser scanning confocal microscopy 
to monitor blood flow in the retina. Using this combined imaging system, blood velocity 
changes were measured with LSF and arteriole diameter monitored with confocal line 
scans while retinal photoreceptors were stimulated by modulating the laser light from the 
secondary scanner of the confocal microscope. In contrast to other methods of 
measuring blood flow, LSF has the distinct advantage of permitting blood velocity to be 
monitored with high spatial and temporal resolution. 
 
We illuminated the retina for LSF with 808 nm light delivered through an optical fiber 
pressed against the sclera. This method has several advantages. First, photoreceptors 
are largely insensitive to this infrared wavelength. Thus, retinal blood flow can be 
monitored without stimulating retinal neurons. Second, either the retinal vasculature or 
the choroidal circulation can be imaged with LSF, depending on the position of the 
illuminating optical fiber. Although LSF has previously been used to monitor choroidal 
blood flow in patients with polypoidal choroidal vasculopathy127 and flow in the sub-
foveal region of healthy subjects133, our work is, to our knowledge, the first to image 
blood flow in an extended network of choroidal vessels in the healthy eye. This 
technique may prove useful in future studies of the regulation of choroid blood flow 
under normal and pathological conditions. 
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Many previous studies have characterized retinal blood flow changes evoked by light 
stimulation109. However, this is the first study to evaluate the spatial distribution of blood 
flow increases evoked by focal stimulation. We found that focal retinal stimulation 
evoked local increases in blood flow. This demonstrates that the retina has the ability to 
control blood flow at a local level. As in the brain, local control of blood flow in the retina 
allows needed O2 and nutrients to be supplied to active neurons efficiently, without 
increasing the supply to inactive retinal regions. 
 
Activity-dependent increases in blood flow in the brain were first described well over a 
century ago27, 28. Yet, the identity of the vessels which mediate this functional hyperemia 
response remains in question. Earlier studies suggested that a large fraction of 
hemodynamic resistance in the brain lay within large cerebral arteries134 or smaller, 
precapillary arterioles135 and it was thought that dilation of these vessels was responsible 
for increased blood flow136, 137. More recently, it has been suggested that capillaries may 
contribute to the regulation of blood flow in the brain. A theoretical study suggested that 
up to 70% of the total hemodynamic resistance in the brain vasculature lies in the 
capillary bed138. In addition, pericytes, which control capillary diameter, have been 
shown to contract or relax in response to neurotransmitters and neuronal activity139-141. 
 
The LSF results presented here bear on this issue and suggest that in the retina, 
activity-dependent blood flow changes are controlled largely by arterioles and that 
capillaries contribute little to the response. If capillary dilation contributed to functional 
hyperemia, focal stimulation of a region devoid of arterioles would result in increased 
blood flow to that region. However, we found the opposite to be true. When the retina 
was stimulated near a primary venule or in a region distant from arterioles, little increase 
in blood velocity was seen in the stimulated region. Rather, blood velocity increases 
were largest in the arterioles serving the stimulated region. In addition, blood velocity 
increases in the stimulated region of the retina were no larger than in an annulus 
surrounding this region. These results suggest that capillaries do not actively dilate in 
response to local neuronal activity and that more distant arterioles mediate the functional 
hyperemia response. The results must be interpreted with caution, however, as our LSF 
technique may not be sensitive enough to detect small changes in blood velocity in the 
capillary bed. 
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Previous studies have demonstrated that local arteriole dilations can be propagated 
upstream, leading to the dilation of larger arterioles and arteries feeding the stimulated 
vessels142, 143. Our LSF results are consistent with this view. When a focal retinal 
stimulus was near a second or third order arteriole, increased retinal blood velocity was 
observed, not only near the stimulated arteriole, but also near the primary, upstream 
arteriole (Fig. 3.4E). 
 
We found that light-evoked velocity increases in primary venules were smaller than 
those observed in primary arterioles. This result appears at first to be paradoxical, as all 
blood flowing into the retina through primary arterioles must exit the retina through the 
venules. We attribute this discrepancy to the fact that primary venules in the retina are 
significantly larger in diameter than primary arterioles. Thus, for the same increase in 
total blood flux, velocity would increase to a smaller extent in venules than in arterioles. 
The differences in observed velocity increases are also attributable to the different time 
courses of the responses in arterioles and venules. Blood velocity amplitudes were 
measured during the initial, transient phase of the response (2–5 s after stimulus onset) 
while, in some cases, responses in venules were larger during the sustained portion of 
the response (Fig. 3.4I, trace 1). 
 
We believe that the combined use of LSF and confocal microscopy holds great promise 
for studying the regulation of blood flow, both in the normal retina and in the retina under 
pathological conditions. A few examples illustrate the potential of this preparation. 
 
 Preliminary experiments from our laboratory demonstrate that retinal glial cells 
can be labeled with Ca2+ indicator dyes and filled with caged-Ca2+ compounds 
introduced into the vitreous humor through a hypodermic needle inserted through 
the sclera. Photolysis of caged-Ca2+ by short wavelength pulses delivered by a 
confocal microscope generate Ca2+ increases in the labeled glial cells. The role 
of glial cells in regulating retinal blood flow can be evaluated using this 
technique21, 144. 
 Preliminary studies show that ischemia can be produced in a restricted region of 
the retina by photothrombosis generated by confocal illumination and bleaching of 
a photo-labile dye, such as rose bengal34. The effect of the thrombolytic lesion on 
blood flow in the penumbra can then be studied with LSF. 
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 Preliminary experiments demonstrate that blood vessels and blood flow in the 
mouse retina can be imaged with the same LSF/confocal microscopy techniques 
we describe here for the rat.  
 
The potential of this preparation for characterizing mechanisms mediating functional 
hyperemia in health and disease will be expanded tremendously with the use of 
transgenic mouse lines.  
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CHAPTER 4:  
Assessment of glial function in the in vivo retina 
 
 
Summary 
Glial cells, traditionally viewed as passive elements in the CNS, are now known to have 
many essential functions. Many of these functions have been revealed by work on retinal 
glial cells. This work has been conducted almost exclusively on ex vivo preparations and 
it is essential that retinal glial cell functions be characterized in vivo as well. To this end, 
we describe an in vivo rat preparation to assess the functions of retinal glial cells. The 
retina of anesthetized, paralyzed rats is viewed with confocal microscopy and laser 
speckle flowmetry to monitor glial cell responses and retinal blood flow. Retinal glial cells 
are labeled with the Ca2+ indicator dye Oregon Green 488 BAPTA-1 and the caged Ca2+ 
compound NP-EGTA by injection of the compounds into the vitreous humor. Glial cells 
are stimulated by photolysis of caged Ca2+ and the activation state of the cells assessed 
by monitoring Ca2+ indicator dye fluorescence. We find that, as in the ex vivo retina, 
retinal glial cells in vivo generate both spontaneous and evoked intercellular Ca2+ waves. 
We also find that stimulation of glial cells leads to the dilation of neighboring retinal 
arterioles, supporting the hypothesis that glial cells regulate blood flow in the retina. This 
in vivo preparation holds great promise for assessing glial cell function in the healthy and 
pathological retina. 
Introduction 
The vertebrate retina is an easily accessible part of the CNS and has proved to be a 
valuable preparation for characterizing glial cell properties and functions. The 
mammalian retina possesses two types of macroglial cells: astrocytes, which are 
confined largely to the innermost retinal layer, and Müller cells, which are radial glial 
cells that span the entire thickness of the retina. In many respects, Müller cells function 
as astrocytes in those retinal layers where true astrocytes are absent11.  
 
Previous work, utilizing both isolated retinas and retinal slices, has revealed several 
important functions of retinal glial cells. Müller cells regulate extracellular K+ levels145. 
When active neurons release K+, Müller cells transfer this K+ to the vitreous humor by 
the process of K+ siphoning20. Müller cells also regulate glutamate levels through the 
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action of their high affinity glutamate transporter146. Müller cells are stimulated by 
neuronal activity, generating increases in intracellular Ca2+ in response to the release of 
neurotransmitters147. In turn, stimulated Müller cells release ATP, which modulates 
retinal activity by hyperpolarizing ganglion cells, the output neurons of the retina15, 148.  
 
Recently, we demonstrated that glial cells mediate functional hyperemia in the retina21. 
When retinal neurons are stimulated by light, retinal arterioles dilate, bringing additional 
O2 and nutrients to the active neurons. This response is mediated in large part by retinal 
glia, which release vasoactive agents that dilate retinal arterioles30. Previously, glial cell 
control of arteriole diameter was characterized in the isolated retina21, 149. This 
preparation is useful for several reasons. Retinal neurons and glia can be patched in the 
isolated retina so that their membrane potential can be monitored and controlled. The 
diameter of retinal vessels can also be monitored with high precision and the retina 
easily perfused with drugs in this preparation. However, the isolated retina has 
significant disadvantages in studying mechanisms mediating functional hyperemia. 
Blood does not flow through vessels and vessels do not have normal tone in the isolated 
retina. These factors can dramatically alter vascular responses. In addition, O2 and NO 
levels, which both influence functional hyperemia21, 150, may not be normal in the isolated 
retina preparation.  
 
In order to circumvent the problems associated with the isolated retina, we have 
developed an in vivo preparation to characterize the role of glial cells in mediating 
functional hyperemia in the retina. Retinal glial cells can be labeled with Ca2+ indicator 
dyes, allowing their physiological state to be monitored with florescence microscopy. 
They can also be filled with caged Ca2+ compounds so that they can be stimulated by 
short wavelength light pulses. Retinal blood flow can be monitored in the in vivo 
preparation with both confocal microscopy and laser speckle flowmetry (LSF)102. Thus, 
the role that glial cells play in regulating retinal blood flow can be characterized using 
this in vivo preparation. In this chapter, we describe materials and methods for 
conducting in vivo experiments to assess retinal glial cell function. 
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Figure 4.1. Glial cells of the retina. Glial cells (green) are labeled with the Ca2+ 
indicator dye Oregon Green 488 BAPTA-1 and vessels (orange) by intravenous ejection 
of dextran rhodamine B isothiocyanate in this confocal image of the retina. Several 
astrocytes (arrows) are visible. Most of the remaining labeled cells are Müller cells. 
Some Müller cells (arrowheads) are seen surrounding unlabeled somata of retinal 
ganglion cells. Scale bar, 100 μm. 
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Figure 4.2. Glial-evoked dilation of retinal arteriole. (A) Confocal image of the retina, 
showing OGB-labeled glial cells and an arteriole (a) labeled with dextran rhodamine B 
isothiocyanate. The luminal diameter of the arteriole is monitored with confocal line 
scans (the white line across the vessel). Asterisk indicates the site of caged Ca2+ 
photolysis; scale bar, 25 μ m. (B) Glial Ca2+ fluorescence measured near the arteriole. 
Photolysis of caged Ca2+ evokes a glial Ca2+ increase. (C) The luminal diameter of the 
arteriole. Photolysis evokes a transient increase in vessel diameter.  
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Results 
Assessing Glial Function 
Previous work using the ex vivo isolated retina preparation demonstrated that retinal glial 
cells could communicate with each other through the generation of Ca2+ increases and 
intercellular Ca2+ waves. When a single glial cell is stimulated with a chemical, electrical, 
or mechanical stimulus, a Ca2+ increase is evoked in the stimulated cell. This Ca2+ 
increase propagates outward into neighboring astrocytes and Müller cells as a Ca2+ 
wave110. Spontaneously generated glial Ca2+ waves are also observed151. It was not 
known, however, whether these intercellular glial Ca2+ waves occur in vivo. The 
preparation described in this chapter has been employed to test whether glial Ca2+ 
increases and waves occur in vivo. 
Glial Regulation of Blood Flow 
1. Retinal glial cells are labeled with OGB and caged Ca2+, and vessels labeled by 
intravenous injection of dextran rhodamine B isothiocyanate (Fig. 4.1).  
2. Glial cells near a primary arteriole are stimulated by photolysis of caged Ca2+, 
while the luminal diameter of the arteriole is monitored with confocal line scans. 
As described above, glial cell stimulation evokes Ca2+ increases in the stimulated 
cells. When glial cells adjacent to an arteriole are activated, an increase in 
arteriole diameter is evoked (see Fig. 4.2). These results demonstrate that glial 
cells can control vessel diameter in vivo and support the hypothesis that glial 
cells mediate functional hyperemia in the retina. 
Glial Ca2+ Increases 
1. Spontaneous Ca2+ waves. Retinal glial cells are labeled with OGB, and confocal 
images of the labeled glial cells are acquired at a frequency of ~1 Hz. 
Spontaneous increases in glial Ca2+ that propagate outward into adjacent glial 
cells at a velocity of ~22 μm/s are observed151, demonstrating that spontaneous 
intercellular glial Ca2+ waves do occur in vivo. 
2. Photolysis-evoked Ca2+ increases. Retinal glial cells are labeled with OGB and 
caged Ca2+. Glial cells are stimulated by photolysis of caged Ca2+ while confocal 
images of the labeled glial cells are acquired at a frequency of ~1 Hz. Glial cell 
stimulation evokes Ca2+ increases in the stimulated cells. The increases in glial 
Ca2+ are proportional to the duration of the photolysis flash, with short flashes  
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Figure 4.3. Glial cell Ca2+ increases. (A) Intracellular glial Ca2+ increases evoked by 
photolysis of caged Ca2+. Photolysis evokes Ca2+ increases proportional to the duration 
of the photolysis flash. Numbers indicate flash duration for each trial. (B, C) Glial Ca2+ 
increases and a propagated Ca2+ wave evoked by photolysis of caged ATP. (B) A 
confocal image of the retina showing OGB-labeled glial cells. Asterisk indicates the site 
of caged ATP photolysis; scale bar, 50 μ m. (C) Stimulation of glial cells by photolysis of 
caged ATP in the vitreous humor evokes Ca2+ increases in the stimulated cells and 
initiates a propagated Ca2+ wave. Ca2+ is measured in the three regions indicated in (B).  
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3. evoking small, brief increases and longer flashes evoking larger, more prolonged 
increases (see Fig. 4.3A). In many trials, photolysis of caged Ca2+ triggers  
4. propagated Ca2+ waves traveling through adjacent Müller cells and astrocytes. 
The results demonstrate that, as in the isolated retina110, 116, photolysis of caged 
Ca2+ in vivo is effective in stimulating retinal glial cells and that glial cell 
stimulation leads to the initiation of intercellular glial Ca2+ waves. 
5. ATP-evoked Ca2+ waves. Retinal glial cells are labeled with OGB. Glial cells are 
stimulated by photolysis of caged ATP in the vitreous humor while confocal 
images are acquired at a frequency of ~1 Hz. 10 μL of caged ATP solution (2 mM 
in saline) is injected into the vitreous humor near the retinal surface. The caged 
ATP is activated by brief (0.2–1 s), focused (5 μm diameter) flashes of 405 nm 
light. The released ATP stimulates retinal glial cells, evoking large increases in 
Ca2+ in the stimulated cells and initiating propagated Ca2+ waves (see Fig. 4.35B, 
C). 
The results demonstrate that, as in the isolated retina116, activation of purinergic 
receptors evokes Ca2+ increases in retinal glial cells in vivo. Activation of retinal 
neurons by photic stimuli results in the dilation of retinal arterioles and increases in 
retinal blood flow109. This response, termed functional hyperemia, brings added O2 
and glucose to the active neurons. Although the cellular mechanisms that mediate 
functional hyperemia remain controversial, recent evidence indicates that glial cells 
play a principal role in coupling neuronal activity to vessel dilation30. We have shown 
that in the isolated retina, stimulation of glial cells results in the dilation of adjacent 
arterioles21. It is not known, however, whether glial stimulation in vivo leads to vessel 
dilation in the retina. The preparation described in this chapter has been employed to 
test whether glial cells regulate the diameter of retinal vessels in vivo. 
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CHAPTER 5:  
Ischemia-induced spreading depression in the  
in vivo retina 
 
1 
 
Summary 
Cortical spreading depression (CSD) is a metabolically costly phenomenon that occurs 
in the injured brain and contributes to tissue damage. In the retina, spreading depression 
has only been studied in ex vivo, avascular preparations. Here, we report that spreading 
depression occurs in the in vivo rat retina in response to occlusion of retinal blood 
vessels. The properties of retinal spreading depression (RSD) and CSD are similar. RSD 
waves have a propagation velocity of 3.0 ± 0.1 mm/min and are associated with a 
negative shift in DC potential, a transient cessation of neuronal spiking, constriction of 
arterioles, and a drop in tissue O2 tension. The frequency of wave generation is reduced 
by MK-801 and sumatriptan. As in the brain following ischemic stroke, RSD waves may 
occur in patients with branch retinal vein occlusion and related vascular disorders. 
Blocking RSD in these patients may reduce vision loss caused by vessel occlusion. 
Introduction  
Cortical spreading depression (CSD) was first described by Leão in the rabbit cortex49 
and has since been characterized extensively53, 54. Its hallmark feature is a wave of 
extreme cellular depolarization that spreads over the cortical surface at a velocity of ~3 
mm/min. This wave is accompanied by large shifts in transcellular ion gradients, cell 
swelling, and increased extracellular concentrations of neurotransmitters, particularly 
glutamate49, 53, 55. CSD is characterized electrophysiologically by a negative shift in DC 
potential and a transient period of increased neuronal spiking followed by a cessation of 
neuronal activity that persists until ion gradients are reestablished53. K+ and glutamate 
released from neurons are believed to overwhelm local glial K+ buffering and transmitter 
uptake mechanisms to generate and propagate CSD54, 72. 
 
CSD results in a complex series of blood flow changes54. In its earliest phase, blood 
vessels constrict, mediated by the release of K+ and vasoconstrictors from neurons and 
glia during wave propagation54, 67, 68. This initial drop in blood flow is followed by a period 
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of hyperemia that lasts for several minutes and then by a persistent oligemia lasting for 
over an hour after the CSD episode65.  
 
CSD can occur in both healthy and injured tissue. In the healthy brain, CSD is the 
mechanism that underlies migraine auras and their subsequent scotomas51, 53. The brain 
fully recovers from such CSD episodes without lasting consequences. However, in 
pathology, such as severe stroke, subarachnoid hemorrhage, or traumatic brain injury, 
CSD events are initiated at the borders of the injured tissue47, 48, 52. The combination of 
high extracellular levels of excitatory amino acids, increased metabolic demand, the long 
lasting oligemia induced by CSD waves results in excitotoxicity and metabolic supply-
demand mismatch, ultimately leading to additional cell death and injury expansion47, 60, 62, 
152. In subarachnoid hemorrhage patients, tens of CSD episodes are sometimes 
generated in the days following the initial ischemic insult, resulting in delayed 
neurological deficits corresponding with secondary ischemic infarcts60. 
 
Spreading depression can occur in the retina as well as the cortex59, 70, 76. However, 
retinal spreading depression (RSD) has previously been observed only in ex vivo 
preparations from species that have avascular retinas70, 72-74. Like CSD, RSD can be 
initiated experimentally by exogenous glutamate application75, altering ion 
concentrations (elevating K+ or lowering Cl-)72, by mechanical stimulation59, or by 
traumatic injury76. Ex vivo RSD and CSD have similar propagation velocities and 
electrophysiological characteristics77. However, RSD has never been described in vivo 
and it has been questioned whether it may be an artifact of ex vivo preparations54. 
We now demonstrate for the first time that RSD occurs in vivo. RSD episodes are 
generated following the experimental occlusion of retinal vessels, suggesting that RSD 
may also occur in patients with branch retinal vein occlusion (BRVO) and related 
vascular disorders. RSD waves have similar properties as CSD waves and are 
accompanied by a series of blood flow changes that may contribute to tissue damage. 
We find that RSD can be blocked by several agents, including MK-801 and sumatriptan, 
suggesting a therapeutic strategy for reducing vision loss in BRVO patients.  
Results  
We investigated whether an ischemic insult in the retina evokes spreading depression, 
as it does in the cortex53, 54. A photothrombosis model of focal retinal ischemia was used 
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to generate blood clots in primary retinal arterioles and venules. Rose Bengal was 
injected i.v. and bleached with 559 nm light focused onto single vessels to form a 
thrombus. The intrinsic optical signal (IOS) of the retina was monitored at 405 nm with 
reflectance microscopy to detect RSD episodes while the Rose Bengal-filled vasculature 
was imaged with confocal microscopy. Concurrent laser speckle flowmetry permitted 
real-time visualization of blood flow changes to confirm blockage of blood vessels and to 
map regions of retinal ischemia.  
 
Photothrombosis completely blocked blood flow in the treated vessels and reduced 
blood flow in the adjacent tissue (Fig. 5.1a & b). Confocal microscopy and laser speckle 
flowmetry confirmed that the occluded vessels remained blocked for > 60 min. Animals 
then recovered and retinas were harvested after a 2 week survival period. Retinal 
ganglion cells (RGCs) were labeled with an anti-Brn3a antibody. Low power confocal 
images show a clearly defined region devoid of RGCs which was centered on the 
occluded vessel (Fig. 5.1c). The absence of RGC labeling was due to a loss of cells 
rather than a loss of Brn3a immunoreactivity, as demonstrated by differential 
interference contrast microscopy images showing an absence of cells in the affected 
retinal region (Fig. 5.1d & e). No such loss of RGCs was observed when vessels were 
bleached in the absence of Rose Bengal. 
Occlusion of blood vessels evokes retinal spreading depression 
RSD waves were generated in every instance when a primary branch arteriole (n=15) or 
venule (n=3) was occluded (Fig. 5.2a & b). The properties of the RSD waves are 
detailed in Table 5.1. On average, 3.7 ± 0.6 waves were generated within the first hour 
following vessel occlusion, with few waves (0.2 ± 0.2) generated after this time. Latency 
to generation of the first wave following vessel occlusion was 7.9 ± 1.4 min. RSD waves 
had a propagation velocity of 3.0 ± 0.1 mm/min (n=58 waves, 15 rats), similar to that 
observed in CSD. The majority of RSD waves (81%) were initiated near the optic disc 
and propagated outward towards the retinal periphery. Occasionally (12.1%), waves 
were initiated at the periphery and propagated inwards towards the central retina. In a 
subset of these pheripherally-initiated episodes, the waves reversed direction and/or  
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Table 5.1. Properties of retinal spreading depression waves. 
 
RSD Properties Mean ± SEM (n rats) 
Number of waves per 
animal following occlusion 
 
0-15 minutes 1.33 ± 0.21 (15) 
16-30 minutes 1.47 ± 0.31 (15) 
31-45 minutes 0.53 ± 0.40 (15) 
46-60 minutes 0.33 ± 0.21 (15) 
60+ minutes 0.20 ± 0.20 (15) 
TOTAL 3.87 ± 0.70 (15) 
Latency to first wave (sec) 475 ± 85 (15) 
Propagation velocity 
(mm/min) 
3.0 ± 0.1 (15) 
Size (radius, µm) 1104 ± 41 (15) 
Site of initiation  
Optic disc 47/58 (15) 
Periphery 7/58 (15) 
Bleach site 4/58 (15) 
Arteriole constriction (µm) 4.7 ± 1.1 (5) 
pO2 decrease (mmHg) 11.7 ± 1.4 (5) 
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Figure 5.1. Photothrombosis model of branch retinal vessel occlusion.  (a) 
Reflectance image of the retina with a superimposed confocal image of Rose Bengal-
labeled blood vessels (red). Vessel occlusion was produced by photoactivation of Rose 
Bengal in two branches of a primary venule (yellow dots). Red circles in this and other 
panels indicate the optic disc. (b) Ratio laser speckle flowmetry image of the retina 
shown in a. Photothrombosis produced a complete block of blood flow in the two 
occluded vessels (dark blue) and a partial block of blood flow in the adjacent tissue (light 
blue). (c) Quantification of the relative blood flow decrease measured by laser speckle 
flowmetry. Blood flow, measured at the red dot in b, decreases to 0% by the end of the 
photothrombosis period. (d-f) Photothrombosis of a single arteriole produced large-scale 
loss of retinal ganglion cells (RGCs) in the region supplied by the vessel following a 2 
week survival time. Immunohistochemical labeling of RGCs (d) reveals a complete 
absence of cells in the region supplied by the occluded vessel (yellow dot). Differential 
interference contrast microscopy demonstrates an absence of cells in the ischemic 
region (e), compared to a healthy region far from the thrombus (f). V, vessel.  
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Figure 5.2. Retinal spreading depression occurs following vessel occlusion. (a) 
Intrinsic optical signal (IOS) images of a representative RSD event in response to focal 
thrombosis of an arteriole (yellow dot). Numbers in the upper right of each panel in this 
and other figures indicate time relative to RSD initiation. (b) Images from the series 
shown in a processed with each frame representing the Δ intensity/intensity (I/I) to 
better visualize the RSD wave front. Most RSD waves are initiated near the optic disc 
(red circle). (c) A RSD wave initiated following onset of global ischemia, produced by 
increasing intraocular pressure to 120 mmHg. The wave was initiated near the optic disc 
(red circle). 
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generated a secondary wave after reaching the optic disc and propagated outward 
again. This secondary wave always propagated into areas of the retina that had not 
sustained the initial wave. Rarely (6.9%), waves were initiated near the site of 
photothrombosis.  
 
Accumulation of free radicals has been reported to initiate spreading depression in both 
the ex vivo retina59, 70 and the cortex153. It is possible that the RSD waves we observed 
were initiated by this mechanism rather than by ischemia, as photothrombosis produces 
thrombi through free radical generation59, 70. If this were the case, then activating Rose 
Bengal in a retinal region containing capillaries rather than large vessels would also 
generate RSD. However, photothrombosis of capillaries produced no RSD events (n=3). 
Nor were RSD waves generated by photobleach illumination in the absence of Rose 
Bengal in the vasculature (n=6). In an additional control experiment, we tested whether 
RSD episodes were generated in a model of retinal ischemia where free radical 
production by photothrombosis was absent. Blood flow in the entire retinal circulation 
was blocked by raising intraocular pressure to ~120 mmHg. An RSD wave was 
generated within 1.5 - 2.3 min (n=3 waves in 3 animals) of blocking blood flow (Fig. 
5.2C). Interestingly, in this global model of ischemia, only one RSD wave was generated 
per animal, rather than the multiple waves evoked by occlusion of a single branch 
vessel. However, if perfusion was reestablished by lowering intraocular pressure within a 
minute after an RSD wave occurred, additional waves could be evoked by subsequent 
increases in intraocular pressure. Together with the observation that RSD episodes are 
rarely initiated at the site of photothrombosis, these data strongly suggest that RSD is a 
response to the acute loss of vessel perfusion. 
Electrophysiological properties of RSD 
We characterized the electrophysiological properties of RSD in both the ex vivo rat 
eyecup and the in vivo rat preparation to determine whether it has the same 
electrophysiological characteristics as CSD. RSD waves were elicited in the eyecup by 
focal ejection of K+ gluconate and were monitored by imaging IOS of the retina with 
reflectance microscopy. Concurrently, extracellular field recordings were made in the 
RGC layer. A negative shift in DC potential and a brief burst of RGC spiking followed by 
the silencing of activity was observed when the RSD wave front reached the recording 
pipette (Fig. 5.3a & b; n=3 rats). RSD waves were also evoked in the eyecup by oxygen  
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 Figure 5.3. RSD waves 
have similar 
electrophysiological 
characteristics as CSD 
waves. Left panels show 
reflectance images of the 
retina and the recording 
pipette (white outlines). 
Right panels show IOSs 
of RSD waves (top 
traces) and 
electrophysiological 
responses (bottom 
traces). The IOS signals 
were recorded at the 
retinal locations 
indicated by the red 
squares in the left 
panels. Time course of 
the stimulus is indicated 
by the gray bars in the 
right panels. (a & b) A 
RSD wave in an eyecup 
was initiated by focal K+ 
gluconate ejection 
(outside of the image in 
a). Spike activity of a 
RGC (2nd from bottom 
trace in b) and DC 
potential (bottom trace in 
b) are shown. Upon 
arrival of the RSD wave 
at the recording pipette 
(arrows in B) RGC 
spiking is briefly stopped 
and a negative DC 
potential is generated. (c 
& d). A RSD wave in the 
eyecup is initiated by oxygen/glucose deprivation (OGD). As in b, RGC activity is halted 
and a negative shift in DC potential is recorded upon arrival of the RSD wave at the 
recording pipette. The decrease in spike amplitude after the RSD wave is due to 
movement of the recording pipette. (e & f) A RSD wave is initiated in vivo by 
photothrombosis of an arteriole (yellow dot in E). Upon arrival of the RSD wave at the 
recording pipette (arrows in f) a negative DC potential is seen (bottom trace in f).  
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glucose deprivation (OGD), an ex vivo model of ischemia (n=3 rats). These RSD waves 
had similar electrophysiological properties as those observed in the K+ gluconate model 
(Fig. 5.3C & D). Field potential recordings were also performed in vivo, with RSD waves 
evoked by photothrombosis of a primary branch vessel. As in the ex vivo experiments, a 
negative shift in DC potential was recorded as the RSD wave passed the recording 
pipette (Fig. 5.3e & f; n=3 rats). Together, these experiments demonstrate that the RSD 
waves observed in the retina have similar electrophysiological properties as CSD waves 
and that RSD waves are generated in the OGD model of ischemia. 
Changes in blood flow associated with RSD 
A series of blood flow changes are associated with CSD54, 68, 154. We used a number of 
techniques to determine whether similar blood flow changes are associated with RSD. 
Changes in the diameter of primary arterioles were monitored in vivo with confocal 
microscopy. A dramatic constriction of arterioles was observed as RSD waves passed 
the vessels (Fig. 5.4a & b). Arteriole constriction averaged 10.6 ± 1.8% (4.7 ± 1.1 µm; 
n=5 waves, 5 rats). Arteriole constriction recovered after 36 s. As described by the 
Hagen–Poiseuille fourth power relation, a constriction of 10.6% will result in a 36% 
decrease in blood flow.  
 
Such a large drop in blood flow, coupled with the increased metabolic demand imposed 
by RSD, should lead to a decrease in O2 partial pressure (pO2). We tested this prediction 
by measuring pO2 with an optical O2 sensor at the surface of the retina. The sensor was 
positioned in a region far from the site of photothrombosis and outside the region directly 
affected by the thrombus, identified by laser speckle flowmetry. A rapid drop in pO2 of 
11.6 ± 1.4 mmHg (n=14 waves, 6 rats) was observed as the RSD wave passed the 
sensor (Fig. 5.4c & d). pO2 decreases recovered slowly over 103 ± 10 s (n=14 waves, 6 
rats) and generally returned to baseline or even exhibited an overshoot above baseline 
for RSD episodes that occurred shortly after thrombus formation. However, with 
subsequent RSD waves, baseline pO2 dropped further and remained below pre-
thrombus levels for the remainder of the monitoring session, in one case for over 60 min. 
These experiments demonstrate that RSD waves are accompanied by a transient drop 
in blood flow and a more prolonged decrease in retinal pO2.  
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 Figure 5.4. RSD-
induced alterations 
in retinal blood flow 
and pO2. (a) 
Reflectance image of 
the retina with a 
superimposed 
confocal image of 
Rose Bengal-labeled 
blood vessels (red). 
Photothrombosis of a 
primary arteriole 
(yellow dot) evoked a 
RSD wave. The 
diameter of a second 
arteriole was 
monitored with 
confocal line scans 
(yellow line). (b) 
Diameter of the 
arteriole indicated by 
the yellow line in a. A 
rapid 12% 
constriction of the 
vessel coincided with 
the arrival of the RSD 
wave (arrow). (c) 
Reflectance image of 
the retina, showing 
the O2 probe (P) and 
the O2-sensitive 
probe tip (PT). 
Photothrombosis of 
an arteriole (yellow 
dot) evoked a RSD 
wave. (d) IOSs (top 
four traces) show 
propagation of a RSD wave from the retina in C. The IOSs were recorded at the retinal 
positions indicated by the red squares in c. A large, rapid decrease in retinal pO2 (bottom 
trace) occurs when the RSD wave reaches the O2 probe (arrows). (e) Blood flow in a 
patent primary arteriole distant from the vessel occluded by photothrombosis, measured 
by monitoring red blood cell (RBC) flux. When the occlusion-evoked RSD wave reached 
the patent vessel (arrow), blood flow increased substantially. The blood flow increase 
decayed slowly over an hour. (f) Summary of blood flow changes induced by RSD, 
measured by monitoring RBC flux. Post-RSD flow represents the mean flow during the 
period 24-65 min following RSD wave generation. N=5 animals. 
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Longer-term changes in blood flow following a RSD episode were investigated by 
measuring the flux of labeled red blood cells as they passed through a primary arteriole 
that was not subjected to photothrombosis. Following the brief decrease in blood flow 
described above, there was a prolonged increase in flow which decayed slowly over 
several hours (Fig. 5.4e & f). We did not observe an oligemic phase, which is seen in 
CSD54, 68. 
Pharmacological block of RSD 
BRVO and related vascular disorders are a leading cause of ischemic vision loss5. Our 
data suggests that RSD may accompany such disorders and contribute to tissue 
damage and vision loss in patients. Thus, it would be useful to identify drugs that block 
RSD. We found that the NMDA receptor antagonist MK-801, which blocks CSD55, 155, 
significantly decreased the number of RSD events as well as the size and the velocity of 
the RSD waves evoked by photothrombosis (Fig. 5.5). A second NMDA antagonist, 
memantine, did not have a statistically significant effect on wave number, size, or 
velocity, but the data trended towards a reduction in these measures. Sumatriptan, a 5-
HT(1D) agonist that has been shown to block RSD in the ex vivo retina156, reduced the 
number RSD waves as well, but did not affect size and velocity (Fig. 5.5). 
Discussion 
The results of this study demonstrate, for the first time, that spreading depression can be 
generated in the in vivo retina. Multiple RSD waves were generated following 
photothrombosis occlusion of a primary retinal arteriole or venule. The RSD waves were 
not an artifact of the photothrombosis model of retinal ischemia, as RSD was also 
generated in vivo following global ischemia produced by an increase in intraocular 
pressure and in the eyecup following oxygen/glucose deprivation, an ex vivo model of 
ischemia. RSD waves had similar properties as CSD waves, including similar 
propagation velocities. RSD, as CSD, was associated with a change in the intrinsic 
optical signal of the tissue, a negative shift in DC potential, a transient increase followed 
by a longer silencing of neuronal spiking, a sequence of blood flow changes, and a 
decrease in tissue pO2. Drugs that are effective in blocking CSD, including the NMDA 
antagonist MK-801 and the 5-HT(1D) agonist sumatriptan, were also effective in 
reducing the generation of RSD. 
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Figure 5.5. RSD is blocked by the 5-HT agonist sumatriptan, and by the NMDA 
antagonist MK-801. Drugs were injected i.v. 10 min before photothrombosis at 
concentrations of 3 mg/kg sumatriptan, 3 mg/kg MK-801, and 10 mg/kg memantine. (a) 
Sumatriptan and MK-801 decreased the incidence of wave generation during the first 
hour after photothrombosis. Memantine, another NMDA receptor antagonist, trended 
towards reducing the incidence of wave generation. (b) MK-801 decreased the size RSD 
waves. (c) MK-801 reduced RSD wave propagation velocity. (d) None of the drugs 
affected the site of RSD wave initiation. Regardless of treatment group, waves were 
predominantly initiated at the optic disc. For all panels, n = 5 animals per treatment 
group. 
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Most RSD waves were initiated near the optic disc, regardless of the site of thrombus 
formation. This property of RSD may be related to the nature of Müller cells, the primary 
glial cells in the retina. Müller cells are longer and thinner near the disc, where the retina 
is thickest157. Müller cells are primarily responsible for buffering extracellular levels of 
both glutamate146 and K+20 and thinner cells may be less effective in rapidly removing 
glutamate and K+ from extracellular space157. This reduced capacity for glutamate and K+ 
buffering may render the region near the optic disc more sensitive to RSD initiation. 
 
RSD was accompanied by a pronounced but brief arteriole vasoconstriction followed by 
a prolonged increase in blood flow lasting for an hour. The fact that blood flow increases 
following RSD at the same time that pO2 remains below normal is not necessarily 
contradictory. In the minutes following a spreading depression episode a large metabolic 
demand is imposed on retinal tissue, as glutamate and K+ must be pumped back into 
neurons and glial cells47, 54. The increase in blood flow may result from this increased 
metabolic demand, but may not be sufficient to maintain O2 at normal levels. 
 
Oligemia, the third phase of altered blood flow that often accompanies CSD54, was not 
observed in the retina. The reason for this difference is not clear, but could be related to 
the differing geometries of the retinal and cortical vasculatures. The retinal vasculature is 
restricted to two dimensions158. As such, there are fewer collateral routes for blood to 
supply an ischemic area. If total blood flow into the retina is redistributed across fewer 
vessels, blood flow will increase through the remaining patent vessels, accounting for 
the absence of oligemia. 
 
A wealth of evidence demonstrates that CSD associated with pathology can expand the 
size of tissue damage. CSD events that occur following subarachnoid hemorrhage, 
malignant stroke, or traumatic brain injury can produce a delayed secondary ischemic 
infarct in patients60. In an animal model of ischemic stroke, CSD increases the metabolic 
demand in the penumbra and enlarges the ischemic core47. Blocking CSD events can 
limit injury expansion155, 159 and cell death155, 160. The consequences of RSD on tissue 
damage in the retina are less clear. One study of cut injury-induced RSD in the 
hypoglycemic isolated chick retina found that RSD produced cell death in the macula, 
and that this damage could itself serve as a trigger for additional RSD waves. Blocking 
RSD prevented lesion formation76. Together, observations from the cortex and the 
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isolated retina strongly suggest that RSD has a deleterious effect on retinal health. 
Particularly following injury, such as ischemia, RSD could contribute to the evolution of 
retinal damage.  
 
Our results have important clinical implications. It is not known whether RSD occurs in 
humans. However, given our observations that multiple RSD episodes are generated in 
an animal model of branch retinal vein and artery occlusion, and that CSD occurs in 
analogous vessel occlusions in the human cortex, it is likely that RSD also occurs in 
patients with BRVO and related vascular disorders. As in the cortex, tissue damage 
caused by vessel occlusion in the retina may be exacerbated by RSD episodes. Cell 
death may be reduced in these patients by blocking RSD generation. Importantly, we 
show that an NMDA receptor blocker and a 5-HT(1D) receptor agonist reduce the 
frequency of RSD wave generation. Drugs with these mechanisms of action are already 
clinically approved and may prove to be effective therapeutic agents that reduce vision 
loss in BRVO patients. 
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Chapter 6: General discussion 
 
 
The methods developed and findings presented in this dissertation represent an effort to 
apply available tools in a novel way to study retinal blood flow and understand the 
consequences of blood flow disruption. Retinal vessel occlusion is among the leading 
causes of vision loss5. Previous research has been either clinically oriented, or has 
focused on elucidating the cellular evolution of injury by using histological techniques at 
discrete time points after injury. The data from these studies have been useful to 
understand the natural history of retinal vessel occlusion and the pathological changes 
that retinal tissue undergoes when faced with ischemia. However, research in this field 
can become more translational by combining clinical imaging methods with in vivo 
animal models to enable real-time observation of functional changes at the tissue and 
cellular level in various disease processes. In this thesis work, laser speckle flowmetry 
and in vivo glial Ca2+ imaging techniques already in use in brain research were 
developed for studying the in vivo retina.  
 
LSF was first developed in the retina many decades ago106, but computational demands 
limited the use of this imaging method. Since computers became more powerful and 
readily available, LSF has become a standard tool for studying hemodynamics in the 
brain161. Applying LSF to the retina has been more difficult due to the optical properties 
of the cornea and lens162. However, if these issues can be overcome, as we 
accomplished by illuminating the retina trans-sclerally, LSF offers the strengths of 
noninvasive imaging at high temporal and spatial resolution to generate a two 
dimensional map of blood flow changes. These advantages make LSF a useful tool for 
clinical imaging, and it has been applied to intraoperative brain imaging163, and retinal 
imaging in disease164. We took advantage of these strengths and applied LSF imaging to 
animal models. In Chapter 5, LSF was used in a complimentary fashion to monitor blood 
flow in a model of retinal vessel occlusion. In Chapter 3, we applied LSF to image retinal 
functional hyperemia and discovered that local increases in blood flow are difficult to 
evoke when the stimulus is presented away from an arteriole, suggesting that arterioles, 
not capillaries, and the primary drivers of functional hyperemia. Since this observation, 
complementary techniques have corroborated this finding and shown that retinal 
capillaries dilate very little in response to neuronal stimulation7. 
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Monitoring glial Ca2+ in vivo is a useful way to assess glial function and determine glial 
contributions to neurovascular coupling and pathophysiology. While Ca2+ indicator dyes, 
such as OGB (Chapter 4) have been applied to study cortical astrocyte function, in vivo 
use of these indicators for the study of retinal glia has been more difficult, since the 
retina is more difficult to access for dye administration. We developed a method to 
deliver Ca2+ indicators and caged Ca2+ compounds to the retina by way of intravitreal 
injection. Using these techniques, we demonstrated their utility in studying the role of 
glial Ca2+ in blood flow regulation. However, classical Ca2+ indicators have their 
limitations. First, while they tend to be preferentially taken up by glia, it is impossible to 
rule out some uptake by neurons. Thus, results obtained with these indicators always 
come with the caveat that some of the observed signal may be neuronal165. Secondly, 
their delivery always comes with some trauma. In the brain, they are ejected onto the 
cortical surface, often after exposing the brain through an invasive cranial window. In the 
retina, we must penetrate the globe with a needle and add volume into an enclosed 
space, both altering intraocular pressure. And these compounds are usually dissolved in 
DMSO, a highly toxic substance. Thirdly, the very nature of Ca2+ indicators disrupts 
physiological processes because a fluorescence signal relies on Ca2+ binding to the 
indicator, rather than acting at its target site166.  
 
In response to these limitations, there has been a rise in the use of newly developed 
genetically encoded Ca2+ indicators (GECIs). Unlike classical Ca2+ indicators, GECIs can 
be expressed in a genetic Cre-Lox system that allows the experimenter to regulate gene 
expression by systemic administration of tamoxifen167. However, use of GECIs without 
the need for viral vector delivery is currently limited to mouse lines. For in vivo retinal 
studies, the smaller eye and an apparent increased susceptibility to cataract formation 
make mice a more difficult model system to use than rats. Furthermore, observations 
from functional studies using GECIs to assess glial Ca2+ signaling in the brain have 
contradicted previous findings that used classical Ca2+ indicators, calling into question 
the role of glia in neurovascular coupling165, 168. As a result, there is a new need to 
carefully characterize the functional mechanisms of both Ca2+ indicator techniques to 
resolve these conflicting results.  
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Ongoing work in our laboratory has taken advantage of GECIs to characterize how 
Müller cell Ca2+ becomes altered in ischemic injury, since this topic has remained 
remarkably unexplored. The eventual goal of characterizing glial Ca2+ signals in ischemic 
pathology is to identify the functional consequences of this signaling. It is unclear 
whether increased Ca2+ signaling in ischemia is protective or injurious to the retina. In 
the brain, blocking Ca2+ signaling with Ca2+ chelators was found to be protective34. 
However, glial release of vasodilators occurs in a Ca2+ dependent manner. Could the 
increased glial Ca2+ to release vasodilators be a mechanism by which ischemic tissue 
tries to increase collateral blood flow? Or is increased Ca2+ a response to limited access 
to glucose and O2? Understanding the functional role of glial Ca2+ in pathology could 
provide new clinical interventions that could harness the protective effects of glia or 
block glial contribution to injury. 
 
The mainstay in retinal vessel occlusion therapy has been to manage the secondary 
complications of ischemia, as discussed in Chapter 1. However, these therapies do not 
reverse vision loss and are often laborious for both patient and clinician (ie: monthly 
intravitreal injections). The discovery of RSD in the in vivo, vascular retina has been a 
very exciting finding because it may provide a new therapeutic target that would limit cell 
death, reducing secondary complications and helping to preserve vision. Strong 
evidence from the brain shows that CSD contributes to injury. This is likely to be the 
case in the retina, too. The characterization of RSD in Chapter 5 leaves many 
outstanding questions. From a functional perspective, it is unclear why RSD would be 
generated with such consistency from the optic disc. We have proposed that it may be 
related to the differential Müller cell morphology and K+ buffering and glutamate uptake 
capacity across the retina. This hypothesis needs to be tested. Understanding this 
peculiar susceptibility of the optic disc to generate RSD waves could provide new 
insights into retinal function and the mechanisms of RSD generation.  
 
Additionally, the impact of RSD on injury progression is unknown. Our data shows that 
vessel occlusion produces RGC loss, and several pharmacological agents are able to 
affect RSD frequency, size, and velocity. However, can blocking RSD limit how many 
RGCs die and limit vision loss? Answering this question will be critical for assessing 
whether RSD is a viable target for developing new therapies. However, trying to 
separate drug effects on RSD from drug effects on excitotoxicity will complicate data 
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interpretation, since spreading depression and excitotoxicity are inexorably linked. 
Regardless, the possibility for clinical intervention also relies on answering the biggest 
outstanding question: does RSD occur in humans? This may be a difficult question to 
address since it is also unknown whether RSD continues to occur beyond an hour after 
vessel occlusion. CSD after injury occurs relatively infrequently, and capturing these 
events required a method of chronic monitoring that was unavailable until recently. 
Chronic subdural electrode monitoring finally allowed clinicians to record CSD episodes 
many days after initial injury. A similar advancement in retinal monitoring technology will 
likely be required to identify RSD in human patients, particularly since the latency 
between vessel occlusion and seeking medical care can be hours or days. 
 
The findings presented here have used novel imaging methods in an in vivo rat model to 
demonstrate the involvement of glial Ca2+ signaling on blood flow (Chapter 4), and LSF 
imaging to demonstrate that retinal functional hyperemia is likely driven by arterioles 
rather than controlled at the capillary layer (Chapter 3). Use of these methods to study 
retinal ischemia led to the discovery of RSD, and is the first demonstration of RSD in 
vivo in a vascular retina (Chapter 5). In the future, these techniques can be applied to 
further characterize RSD, particularly with regard to glial Ca2+ signaling and blood flow 
changes.  
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